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1. STEM CELLS   
           1.1 DEFINITION and CLASSIFICATION OF STEM CELLS 
In the last years stem cells have became a new fascinating topic of research 
in biology due to their extensive regeneration potential and their functional 
differentiation capacity. Stem cells rapidly became attractive for many 
applications like tissue engineering, cellular therapies and drug screening. 
The biology of stem cells is very important to understand how an organism 
develops from a single cell and how healthy cells replace damaged cells in 
adult organisms. Stem cells are particular types of cells that differ from 
other kinds of cells in the body. All stem cells- regardless of their source- 
must  fulfill three  criteria (Fig.1) (National Institute of Health, 2002;Ulloa-
Montoya et al.,2005) 
1. They must be capable of self-renewal, i.e. dividing and renewing 
themselves for long periods: when cells replicate themselves 
many time over it is called proliferation. If the cell descendants 
continue to be unspecialized, like the stem cells parents, the cells 
are said to be capable of long term self renewal. 
2. They are unspecialized cells : they don‟t have any tissue-specific 
structures that allow it to performs specialized functions, but 
unspecialized cells can give rise to specialized cells. 
3. They can give rise to specialized cell types: when unspecialized 
cells give rise to specialized cells, the process is called 
differentiation that is trigger by internal signs (cells genes) and 
external signs (cytokines secreted by other cells, physical contacts 
with neighboring cell and different molecules present in the 
microenviroment).  
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Fig. 1: Criteria for definition of “stem cells” 
 
Stem cells are classified according to their differentiation capability. The 
Zygote is defined the totipotent stem, whereas the  Embryonic Stem Cells 
are considered Pluripotent Stem Cells for their capacity to differentiate into 
the three somatic germ layers: mesoderm, ectoderm and endoderm. The 
Adult Stem Cells or Somatic Stem Cells  can be divided into multipotent and 
paucipotent stem cells. The multipotent stem cells maintained the 
undifferentiated state and their multipotentiality through asymmetric 
divisions. The paucipotent stem cells or committed progenitors can 
differentiate only into cells of one tissue or germ layer in which they reside 
like bone marrow, brain, skin, liver, skeletal muscle, peripheral  blood and 
blood vessels.(Fig.2) 
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Fig.2: Classification and destiny of stem cells 
             1.2 THE EMBRYONIC STEM CELLS 
The Embryonic Stem Cells (ESCs) are derived from the inner cell mass of 
the blastocyst from the 3 to 5 day old embryos. These cells can give origin 
to hundreds of highly specialized cells needed to make an adult organism. 
The ESCs have unlimited self renewal and differentiation potential. They 
are capable of giving rise to cells of the three somatic germ layers that 
constitute an organism: mesoderm (muscle, bone), ectoderm (neurons, skin, 
etc.) and endoderm (hepatocytes, pancreatic beta cells,)(Fig.3); for this 
property the ESCs are defined  pluripotent stem cells. 
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                      Fig.3: Characteristics and differentiation potential of ESCs 
 
The ESCs were first isolated from mice in the 1981 (Martin, 1981,Evans et 
al., 1981), then from non human primates and in the 1998 from humans 
(Thomson et al., 1995,1998). At the beginning, ESCs were created for 
infertility purposes through in vitro fertilization procedures and when they 
were not longer needed for that purpose, they were donated for research 
with the informed consent of the donor. Mouse ESCs are able to give rise 
embryogenesis when injected into a pre-implantation embryo, producing 
functional differentiated progeny in all tissue and organs even after 
numerous propagation and manipulation in vitro (Smith, 2001). In theory, 
also the human ESCs should be able to give the same results, but for ethical 
reasons this cannot demonstrated. The pluripotency of ESCs is tested by the 
colony-forming ability in culture, the expression of numerous surface 
markers like SSEA-1 in the mouse and  SSEA3, SSEA-4 and  TRA-1 in 
humans (Henderson et al., 2002, Carpenter e al., 2003). Further it is crucial 
the expression of transcription factor correlated with the stem ability and 
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the undifferentiated state like OCT4, NANOG and SOX2 (Niwa et al., 
2000, Chambers al., 2003, Avilion et al 2003). Besides, the pluripotent 
differentiation of ESCs has been show when they were transplanted into 
post natal animals: they generated tumors called teratomas consisting of 
different type of tissues belong to the three germ layers (Wobus et al, 1984, 
Reubinoff et al., 2000). However, this feature represents a challenge on 
ESCs application for clinical therapies because of the need to control 
undifferentiated cells to avoid teratoma formation after transplantation.  
Another aspect about the property of ESCs that must be considerate for the 
clinical application is their immunogenicity. In particular the ESCs 
expression of Human Leukocyte Antigen Class II (HLA-II) can trigger 
immune rejection in the case of heterologus transplantation. Considering 
this problem and for the ethical issue connected with the ESCs, the 
researchers have addressed their study on the Adult Stem Cells (Watt et al., 
2000). 
 
1.3 ADULT STEM CELLS 
Also the Adult Stem Cells or Somatic Stem Cells answered to the criteria 
that defined Stem Cells. They had a self-renewal degree and differentiation 
potential lower than ESCs. The adult stem cells are undifferentiated cells 
able to renew itself and to differentiate into specialized cell types of the 
tissue or organ in which they reside (multipotent potential). Thus the 
fundamental role of Adult Stem Cells in living organism is to maintain the 
homeostasis and to repair the damaged tissues. Scientists have identified 
adult stem cells in different tissues and this finding had led to speculate if 
these cells are suitable for transplantation. The possibility to control their 
differentiation potential could propose these cells as the best candidate for 
cellular therapy in common diseases (National Institute of Health, 2002). 
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The researches on adult stem cells starts in the 1960 when were found in the 
bone marrow two kind of cells: the HEMATOPOIETIC STEM CELLS 
(Islam, 1985) and the MESENCHYMAL STEM CELLS (Friedenstein et 
al., 1974) (Fig.4). 
 
 
 
Fig.4: The ADULT STEM CELLS in the bone marrow 
 
The most extensively studied adult stem cells are the HEMATOPOIETIC 
STEM CELLS (HSCs): a type of the adult stem that is the source of all 
blood cell lineages. The HSCs were first isolated from bone marrow in the 
mouse (Spangrude et al., 1988) and now they can be obtained in humans 
from bone marrow, peripheral blood and umbilical cord blood (Ulloa-
Montoya, et al., 2005); the human HSCs have been characterized for the 
expression of cell surface marker CD34+/CD38-. The principal role of 
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HSCs is to continuously differentiate into multiple lineages of different 
blood cell types (Fig. 5) , simultaneously replicating themselves through 
self-renewal to prevent depletion of the stem cells pool in the bone marrow 
(Huang et al, 2007). 
 
 
 
Fig.5: HSCs and their differentiation lineages 
HSCs are used in the clinical practice (bone marrow transplantation) for 
reconstitution of patient‟s hematopoietic system after undergoing 
chemotherapy or radiotherapy to treat cancer and diseases such as aplastic 
anemia, thalassemia, etc. (Ulloa-Montoya et al.,2005). Bone Marrow-HSCs 
(BM-HSCs) are normally quiescent, the fate choice to either self-renewal or 
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differentiate is controlled by complex interplay mechanisms between 
intrinsic and extrinsic signals, e.g the microenvironment of the niche in 
which they reside. Furthermore, it is well demonstrated that the HSCs 
undergo asymmetrical divisions, in which individual HSCs give rise to non 
identical cell descendants, one keeping the features of HSCs and the other 
becoming a differentiated progenitor cell. External environmental signals 
must integrate with intrinsic molecular mechanisms to control the fate 
decisions of  HSCs. In particular several transcription factors, playing as 
intrinsic molecular mechanism, are implicated in the regulation of self 
renewal like: Transcription factor translocation Ets leukemia (tel)(Hock et 
al., 2004), Hox4 (Sauvageau  et al., 2004), Stat5 (Kato et al., 2005), Stat3 
(Chung et al., 2006). In addition several proteins involved in the 
modulation of gene expression have been found to regulate HSCs self-
renewal like BMI-1,which, together with  proteins, leading to the repression 
of transcriptional activity through the maintaining of epigenetic memory 
(Iwama et al., 2004). On the other hand, the environment signals implicated 
in the regulation of HSCs self renewal are numerous like the transduction 
pathways of Notch, WNT, BMP and Sonic hedgehog (Shh). Functional 
genomics and newly developing technologies will continue to extend the 
understandings of HSCs characteristics in order to obtain protocols for 
HSCs in vitro generation, expansion and of differentiation control (Huang 
et al., 2007).  
Different kind of adult stem cells have been studied although they are not 
well characterized as HSCs. Neuronal stem cells give rise to neurons, 
astrocytes and oligodendrocytes (Gage et al.,2000), where as Mesenchymal 
stem cells can differentiate into fibroblast, osteoblastas, chondroblasts, 
adipocytes and skeletal muscle (Friedestein, 1982, Prockopt 1997, 
Pittenger et al., 1999). In the last years, other stem cells have been 
identified like gastrointestinal stem cells (Potten, 1998), epidermal stem 
cells (Watt, 1998) and hepatic stem cells (Alison, 1998). Recently a new 
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population of pluripotent stem cells defined Multipotent adult progenitors 
cells (MAPC) have been isolated from bone marrow of post natal human 
and rodents, that can differentiate in vitro in cells of the three germ lineages 
(Reyes et al., 2001). 
The hypothesis that Somatic Stem Cells can differentiate only in the cell 
types of the tissue in which they reside has been revaluated. In the last 
years, several experiments showed the possibility that adult stem cells from 
one tissue may be able to give rise to cell types of a completely different 
tissue . This Property is called Plasticity (Fig.6). For example, bone marrow 
derived cells differentiate or trans–differentiate into myoblasts (Ferrari et 
al,1998), endothelium (Rafii et al., 1994, Asahara et al., 1997, Lin et al., 
200, Orlic et al., 2001), liver, biliary duct (Peterson et al., 1999, Theise et 
al 2000), lung, gut (Lagasse et al., 2000) or neural tissue (Mezey et al., 
2000); MAPC were shown to differentiate into neurons and hepatocytes 
(Zhao et al 2002, Schwartz et al., 2002); neuronal stem cells differentiate 
into hematopoietic stem cells (Bjornson et al.,1999), bone marrow cells 
regenerate infarcted  myocardium (Orlic et al, 2001) and Mesenchymal 
Stem Cells (MSCs) from fetal membrane enhanced cardiac repair in 
infarcted rat hearts when induced in culture with a mixed ester of 
hyaluronan with butyric and retinoic acid (HBR) (Ventura et al., 2007). 
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Fig.6: Plasticity of Adult stem cells 
Even if cumulative experimental in vitro and in vivo evidences suggested 
the plasticity of the adult stem cells lines, their clinical use can be consider 
safety in replacing cells and human tissues. Finally, the ability of adult stem 
cells to differentiate into specific cell types offer the possibility of a 
renewable sources of replacement cells and tissues to treat diseases like 
Parkinson, Alzheimer, stroke, heart disease, diabetes and rheumatoid 
arthritis. However the principal problem for the therapeutically use of adult 
stem cells is the lack of a sufficient number of stem cells available. Unlike 
embryonic stem cells,  adult stem cells like MSCs lacked telomerase 
activity (Zimmermann et al., 2003) and showed limited ex vivo 
proliferation capability, reaching senescence and losing multilineage 
differentiation potential after 34-50 population doublings in culture. 
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1.4 MESENCHYMAL STEM CELLS 
For many years the researchers hypothesized the presence of cells with the 
property of stem cells among the  non hematopoietic stem cells. The 
pioneering work of Friedestein et al, who first demonstrated that bone 
marrow derived cells were capable of osteogenesis (Friedenstein et al., 
1961), described the existence of a subpopulations of stromal cells that 
support normal adult hematopoiesis (Dexter et al., 1977, Calvi et al, 2003). 
The Term Mesenchymal Stem Cells (MSCs) was popularized by Caplan 
(Gao et al 2001) describing a cell with a fibroblast like morphology isolated 
by Percoll density centrifugation that grew adherent when cultured in a 
plastic support and that expressed SH2 and SH3 antigen. Today the general 
protocol for isolating MSCs from bone marrow involves the isolation of 
mononuclear cells using a gradient centrifugation and seeding these cells on 
tissue culture plates in medium with fetal bovine serum. After attachment of 
the adherent fraction, the medium is removed to eliminate non–adherent 
cells and remaining cells are expanded in vitro for a limited number of 
passages (Ulloa-Montoya et al., 2005). The adjective Mesenchymal can 
give some ambiguity. In fact, the mesenchyme is correlated with tissue of 
mesodermal origin, the middle embryological germ layer, giving rise to 
blood, vascular, musculosketal, urinogenital system and to connective tissue 
including dermis. So, the term mesenchymal should include both blood and 
connective tissue ; in fact, now there are some evidences of the existence of 
a common precursors for the HSCs and endothelial cells (EC), called 
haemangioblast (Ema et al., 2003, Jaffredo et al., 2005), a cell derive from 
embryonal mesoderm. Today, the more reliable hypothesis is that 
hemangioblast derived from mesenchymal stem cells. Accordingly, the 
nomenclature for this type of cells is not consistent, so the cells with non 
hematopoietic multipotency included “ colony-forming units-fibrobalsts”, 
“stromal cells stem”, “mesodermal progenitors cells”, “skeletal stem cells”, 
“mesodermal progenitors cells”, “ non hematopoietic stem cells”, and so on 
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(Sethe et al., 2006). In 2005, the International Society for cellular Therapy 
have defined the nomenclature for MSCs: In this position paper, the Society 
proposed that the plastic-adherent cells currently described as mesenchymal 
stem cells could be termed Multipotent mesenchymal stromal cells, while 
the term mesenchymal stem cells should be reserved for a subset of these 
(or other) cells that demonstrate stem cells ability by clearly stated criteria. 
For both the population, the acronym MSCs may be used (Horwitz et al., 
2005).   
Now is clearly described the presence of a niche within the bone marrow 
that support the survival and the growth of the HSCs. This niche is formed 
by stromal cells (endothelial cells, adipocytes, macrophages, reticular cells, 
fibroblasts, osteoprogenitors cells) and extracellular microenvironment 
where MSCs are presumed to exist (Baksh et al., 2004). Since the early 
work of Castro-Malaspina (Castro-Malaspina et al., 1980), many 
researchers have developed different way to isolate and purified a 
populations of mesenchymal stem cells. In the 1999 MSCs were isolated 
from human post natal bone marrow (Pittenger et al 1999) and even if bone 
marrow is considered a well-accepted source of MSCs, in the last years, 
MSCs were isolated from many other human sources like umbilical cord 
blood (Erices et al., 2000), adipose tissue, connective tissue , peripheral 
blood, skeletal muscle (Baksh et al., 2004) and more recently from 
deciduous tooth (Miura et al., 2003), umbilical cord mesenchime (Romanov 
et al., 2003) and fetal membrane (Zhang et al, 2004, Alviano et al , 2007). 
Term Amniotic membrane is a very attractive source of MSCs due to the 
fact that is a fetal tissue usually discarded without ethical conflicts leading 
to a high efficiency in MSCs recovery with no intrusive procedures(Alviano 
et al., 2007); the umbilical cord blood is rich in MSCs because during 
embryonic development the embryonic hematopoiesis change site: from the 
yolk sac as an  initial site to liver and then to bone marrow with a 
consequent migration of HSCs and MSCs  
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In the last years, considerable progress has been made towards 
characterizing the cells surface antigenic profile of Human bone marrow 
derived MSCs populations using FACS (Fluorescence activated cell 
sorting) and magnetic bead sorting techniques. To date, a single marker to 
definitely delineates this cells has yet to be identified, so now the principal 
criteria for the definition of MSCs are (Prockopt et al, 1997): the ability to 
adhere to tissue culture plastic, the typical fibroblast-like morphology and 
the formation of colonies (termed colony forming unit-fibroblasts [CFU-f]). 
However the primary important feature of MSCs is their ability to 
differentiate in vitro, in different culture conditions, into several cell types 
(Fig.7).  
 
Fig.7: The Mesengenic Process of Mesenchymal Stems Cells 
 
Now is well accepted that MSCs are capable of multipotent differentiation 
into connective tissue like bone, cartilage, tendon  , muscle , adipose tissue, 
hematopoietic supporting stroma (Baksh et al., 2004) and also non-
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mesoderm-type cells, for example, neuronal-like and endoderm-like cells 
(D’Ippolito et al., 2004, Zhao et al, 2002,Sanchez-Ramos et al, 2000). 
The MSCs are a heterogeneous populations in terms of their multilineage 
differentiation potential. For instance, Pittenger et al demonstrated that only 
one-third of the initial adherent bone-marrow derived MSCs clones are 
pluripotent ( osteo/adipo/chondro)(Pittenger et al 1999). Several studies 
both in vivo and in vitro confirmed this observations. (Baksh et al, 2004). 
This characteristic of MSCs, e.g. their heterogeneity, could be  explained by 
the fact that the MSCs in the bone marrow are a pool of cells that comprises 
Mesenchymal stem cells and different subpopulations at different state of 
differentiation. Baksh et al in 2004 suggested a model (Fig.8) in which the 
MSCs in the bone marrow constituted a “primitive stem cells”, like HSCs, 
with multipotent differentiation potential and self-renewal capacity, that 
with asymmetric divisions, give rise to MSCs with limited self renewal and 
different multilineage potential (Baksh et al, 2004). 
         
         Fig.8: Models MSC differentiation (Baksh et al., 2004) 
The multilineage differentiation potential of MSCs remain today an 
important feature to define their stemness by in vitro test. To date a specific 
universal antigen to define the immunophenotype of MSCs is still lacking. 
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For this reason MSCs are described negative for hematopoietic surface 
marker : CD34 ( a transmembrane protein that defined ˜ 1% of normal bone 
marrow mononuclear cells including hematopoietic precursors/stem cells 
and normal endothelial cells), CD45( recognizes a family of proteins known 
as the leukocyte common antigen exclusively expressed on the surface of 
almost all haematolymphoid cells and their progenitors), CD14 (LPS-
receptor) , CD31( glycoprotein also designed platelet endothelial cell 
adhesion molecule-1- PECAM-1-that is normally expressed on endothelial 
cells, circulating and tissue phase hematopoietic cells including platelets, 
monocytes/macrophages, granulocytes and B-cells) and positive for the 
coexpression of several antigen like (D’Ippolito et al, 2004, Short et al, 
2003, Reyes et al 2001, Pittenger et al, 1999):  
 
CD105: this antibody SH2 identifies an epitope of endoglin (CD105), 
the TGFβ receptor III present on endothelial cells, erythroblasts, 
monocytes, and connective tissue stromal cells  and facilitates enrichment 
of stromal progenitors from bone marrow (Short et al., 2003) 
CD166 or ALCAM (activated leucocyte adhesion molecule) : is 
involved in the osteogenic differentiation and also is expressed on 
lymphocyte B, T and macrophages.  
CD54 or ICAM-1: Intercellular adhesion molecule -1 is an inducible 
cell surface glycoprotein expressed at a low level on a subpopulations of 
hematopoietic cells, vascular endothelium, fibroblasts and certain epithelial 
cells. 
CD44 : is a receptor for hyaluronic acid and it is involved in adhesion 
between hyaluronate and other proteoglicans in the extracellular matrix 
including collagen and fibronectin. 
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CD90 or Thy1: a 25–37 kDa heavily N-glycosylated, 
glycophosphatidylinositol (GPI) anchored conserved cell surface protein, 
originally discovered as a thymocyte antigen. Thy-1 can be used as a 
marker for a variety of stem cells and for the axonal processes of mature 
neurons. Structural study of Thy-1 lead to the foundation of the 
Immunoglobulin superfamily. 
CD73: a glycoprotein , identified by monoclonal antibody SH3 and SH4, 
involved in B-cell activation (Short et al., 2003) It is expressed by 
lymphocytes and endothelial cells 
CD29: is a beta 1 hyntegrin involved in the cell-cell interactions and in 
adhesion with extracellular marker. 
In the last years , the research have tried to improved isolation and ex vivo 
expansion of MSCs by optimization of initial plating density, and by a 
immunoselection of  a homogeneous MSCs population based on cell 
surface markers, cell size or expression of telomerase (Ulloya-Montoya et 
al, 2005). STRO-1, yet uncharacterized cell marker,  is one of the first 
antibody used to enrich approximately 10 - 20 fold for CFU-F in fresh 
aspirates of human BM respect their incidence in unsepareted BM. Further, 
the STRO1 enriched subset of marrow cells is capable of differentiating 
into hematopoiesis-supportive stromal cells with a vascular smooth-like 
phenotype, adipocytes, osteoblasts and chondrocytes(Short et al., 2003). 
The use of antibody anti-STRO1 combined with anti-vascular cell adhesion 
molecule-1 (V-CAM-1/CD106) has allowed to obtained a population of 
cells that could be expanded for over of 40 population doublings and that 
showed a 50% cloning efficiency to form CFU-F (Short et al., 2003, 
Ulloya-Montoya et al., 2005). 
For the Immunological profile, Mesenchymal Stem Cells express 
intermediate levels of human leukocyte antigen (HLA) major 
histocompatibility complex (MHC) class I molecules and negligibly low 
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levels of HLA class II and Fas ligand; they do not express the costimulatory 
molecules B7-1, B7-2, CD40, or CD40L. MSCs in vitro were able to 
suppress T-cell proliferation, and intravenous infusion of MSCs didn‟t 
elicited toxicity. The immunosuppressive nature of MSCs is of clinical 
relevance in allogeneic transplantation since it could reduce the incidence 
and severity of graft-vs-host disease (GVD) (Le Blanc , 2003 a,b).  For the 
properties above described ( multipotential potential, extensive self renewal 
and immunological property), adult mesenchymal stem cells shown a great 
promise in cell therapy, gene therapy and in the new emerging area of tissue 
engineering. In several animal transplantation studies , MSCs expanded ex 
vivo were able to differentiate in the cells of the tissue in which they were 
implanted, to repair the tissue and, in some cases, partially to restore its 
normal function  without any immunoreactivity in the host. (Baksh et al, 
2004). Recently, the use, with local implantation, of MSCs or subset of the 
cells with vascular endothelial phenotype or a mixture of hematopoietic 
stem cells have been tried in a small number of patients with vascular 
ischemia (Tateishi-Yuyama et al., 2002), coronary artery disease (Assmus et 
al., 2002), but this results must to be confirmed in a randomized clinical 
trials. In particular the researchers have studied the possibility to use MSCs 
as a carrier to deliver genes into the tissue for gene therapy application to 
either promote repair and regeneration of diseased or damaged tissue or 
rescue defective genes. For this purpose, the researchers have used different 
methods for transfecting MSCs (Kassem et al.,2004). Another important 
area where the use of MSCs seems to be very useful, is the tissue 
engineering. Ex vivo engineering procedures, by the means of three-
dimensional bio-scaffoldf seeded with mature cell or stem cells and 
cultivated in bioreactors, could lead to the formation of tissues or organs  
(Stock, 2001) . Now several kind of scaffolds are available (collagen type 1, 
fibronectin, alginate, polylactide, plyglicolide and different combination) 
and different pre-clinical animal model showed the success of this 
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approach, particularly for treatment of large bone defects (Kon et al., 2000). 
Now there are many researches based on the study of tissue engineering 
with applications in different field of Regenerative Medicine (Fig.9). The 
hope is to achieve an established human transplantation of these engineered 
tissues in the near future. 
                  
Fig.9: Potential use of adult stem cells in regenerative medicine and 
recustructive surgery. (Conrad et al., 2004) 
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2. STEM CELL NICHE 
After birth adult stem cells are located in a special microenviromental 
termed “Niche” , that varies in relationship with the tissue in which they 
reside. The principal role of adult stem cells is to maintained the tissue 
homeostasis , replacing cells lost for natural cell death (apoptosis) or after 
injury. For this particular function, a delicate balance between self-renewal 
and differentiation must be maintained. In the 1978, Schofield, for first, 
hypothesized the presence of the “Niche”, a special microenviromental that 
support the stem cells‟s maintaining (Schofield., 1978). This particular 
structure has the important function to sequester stem cells from stimuli of 
differentiation, apoptosis and others that would challenge stem cells 
reserves. Further, the niche prevents the excessive stem cells production 
that could lead to a cancer development. The stem cell niche is composed of 
cellular components and molecular signals produced by the support cells. 
The studies to identified the niche started in different genetic models like 
Drosophila and C. Elegans. In the last years, different type of Niche in the 
mammals systems have been identified and described (Li et al., 2005). 
 
2.1 THE HEMATOPOIETIC STEM CELLS IN THE BONE 
MARROW 
The HSCs represent the best characterized stem cell population, but little is 
known about the in situ information that define the anatomical and 
structural relationships of stem cells with their progeny and the 
microenviromental cells (Moore et al., 2006). The anatomical sites in which 
this cells reside are located in the bone marrow proximal to the endosteal 
surface of trabecular bone. (Fig .10 A) 
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Fig 10: Stem cells and their niche in the bone marrow . A) HSCs and their 
niche cellular component ; B) possible molecular signals that HSCs send 
and receive for regulating their proliferation and differentiation (Moore et 
al., 2006) 
 
Recently two studies indicated that: 1) osteoblastic cells are required for the 
physically attach of the HSCs in the bone marrow , 2) N-Cadherin/ β 
Catenin complex between HSCs and Osteoblast has been identified 3) 
Jagged1,generated from osteoblasts, influences HSCs by signaling through 
the Notch receptor, 4) the number of osteoblasts controls the number of 
HSC (Calvi et al., 2003,Zhang et al., 2003) 
In vitro studies of HSCs coculture with osteoblasts demonstrated the 
expansion of HSCs (Taiehman et al.,1998), while a depletion of osteoblasts 
leads to the loss of hematopoietic tissue (Visnjic et al., 2004). The 
Osteoblast  presence is relevant and play a fundamental role in the BM-
HSCs niche even if others type of cells may supply the same function. The 
contribution of stromal cells or perivascular cells is yet to be defined.  
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N- Cadherin is fundamental for anchored stem cells to the niche and other 
type of adhesion molecules, like Integrins, are involved (Simmons et al., 
1997) Further, several studies provide direct evidence for the involvement 
of  matrix components in HSCs regulation (Moore et al., 2006). 
 
About the analysis of the molecular signals, different gene expression 
studies of HSCs have revealed some signals involved in the regulation of 
self renewal / differentiation balance (Fig.10B). These components include: 
WNT/β catenin (Reya et al., 2003), important for the maintenance of self 
renewal , Notch that maintained HSCs in undifferentiated state (Calvi et al., 
2003, Ducan et al., 2005), Transforming growth factor βeta –BMP (TGF/β- 
BMP), for the control in the number of HSCs (Zhang et al., 2003). In 
addition, a comprehensive genomic analysis of an HSC-supportive 
microenviromental cells has been performed (Hackney et al., 2002). 
  
2.2. THE EPHITELIAL STEM CELL NICHE IN SKIN 
The hair follicle present in the skin is composed by a basal layer or 
permanent portion that normally give rise to stratified skins layers and a 
specially zone called the Bulge, in which reside the hair follicle stem cells 
that are responsible for the regeneration of hair and sebaceous gland 
(Fig.11A)(Alonso et al., 2003). So, the bulge area is a sort of Niche where 
epithelial stem cells are located and maintained (Niemann et al.,2002, 
Cotsarelis et al., 1990, Sun et al., 1991). This stem cells give rise to 
daughter cells that either migrate upward to serve as epidermal progenitors 
for generating epidermal cells during wound repair or migrate downward to 
convert to hair-matrix progenitors which give rise to the hair shaft 
(Niemmann et al., 2002, Oshima et al., 2001, Taylor et al., 2000). In the last 
years different studies confirmed that the hair follicle stem cells (HFSCs) 
are quiescent. Multipotentiality of single hair follicle stem cells has been 
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shown by using cells expanded in vitro; it is possible that in situ single cells 
in the bulge are destined to produce distinct lineages. Freshly isolated cells 
from bulge have been used as a populations and not as a single cell in 
transplantation (Morris et al., 2004). Such techniques, or an ability to track 
the progeny of single HFSCs in situ, will be required to accurately assess 
the multipotential activity of these cells in normal homeostasis (Moore et 
al., 2006). The molecular analysis performed on the hair follicle stem cells 
reveled the following features (Li et al., 2005): 
 
1 The expression of adhesion molecules is essential for the 
interactions between stem cell and niche 
2 The presence of growth inhibition factors such as TGFβ/BMP 
molecules and cell cycle 
3 The components of Wnt signaling pathways, including receptors 
and inhibitors  
 
The expression of several signaling pathways like WNT and BMP have 
important role in the regulation of HFSCs development and regeneration. 
The WNT/β catenin systems is important for controls the stem cells 
activation, fate determination and differentiation while BMP signaling , as 
opposed to WNT, restricts the activation of stem cells and favors epidermal 
cell fate (Fig.11 B) (Moore et al., 2006). 
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Fig 11: Stem cells within their niche in the hair follicle. A) cells present in 
the hair follicle and B) molecular mechanisms that mediate the hair follicle 
stem cells proliferation ( Moore et al., 2006) 
 
 
2.3. THE INTESTINAL STEM CELL NICHE 
The presence of a stem cell niche,  in the intestine reside in the architecture 
of the epithelial villus-crypt structure based on surrounding perycryptal 
fibroblasts and mesenchymal cells. (Fig.12 A).The intestinal regeneration 
begins with intestinal stem cells that give rise to four different type of cells: 
columnar enterocytes, mucin producing goblet cells, paneth cells and 
eteroendocrine cells (Bjerknes et al., 1999, Hermiston et al., 1995, Winton 
et al, 2000). In every crypt, there are four or six intestinal stem cells that are 
located in a ring from the bottom crypt; the activated intestinal stem cells 
migrate upward to became progenitor or transit amplifying cells and at the 
top of the crypt, they stop proliferating and differentiate (Moore et al., 
2006). The intestinal stem cells (ISCs) are normally quiescent and their 
asymmetric cell division must to be yet demonstrated. The mesenchymal 
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stem cells surround the crypt and during postnatal intestine regeneration, 
play a important role in directing epithelial cell proliferation, differentiation 
and apoptosis; for example BMP4 expressed by mesenchymal stem cells is 
one of the molecular mechanisms purposed for the niche signals (He et al., 
2004). The endothelial cells that composed the vascular vessels provided 
the intestinal stem cells survival with different signals like FGF (Paris et 
al., 2001), while myofibroblasts, that surrounding epithelial cells, are 
proposed to be the candidate “niche” supporting ISCs and influencing other 
epithelial cells (Millis et al., 2001). Also in the intestinal stem cells niche, 
some molecular signals have been proposed for regulate the balance of 
intestinal stem cells between self-renewal and differentiation. (Fig. 12 
B).This molecule and gene expression included WNT, BMP, FGF, Notch, 
Myc, PI3K/Akt (Li et al., 2005). In this complex mechanisms, WNT play a 
positive role in promoting intestinal stem cells activation/self renewal and 
the crypt cell fate (Van de Wetering et al.,2002), while BMP restricts this 
process. (Haramis et al., 2004, He et al., 2004) 
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Fig 12: The intestinal stem cells niche. A) Principal type of cells and their 
spatial disposition in the crypt niche. B) Molecular signals pathways that 
mediate proliferation of Intestinal Stem Cells (Moore et al., 2006). 
 
 
2.4. THE NEURONAL STEM CELL NICHE 
Neuronal stem cells have been identified in the 1990 (Alvarez-Buylla et al., 
1990).The well characterized germinal regions in which the neuronal stem 
cells reside and support the neurogenesis in the adult brain are two 
important regions in the hippocampus: the SUBVENTRICULAR ZONE 
(SVZ) and the SUBGRANULAR ZONE (SGV)(Doetsch et al., 1999, Lois 
et al., 1993,Palmer et al.,1997, Temple et el., 2001). In the SVZ there are 
different kinds of cells. Ependymal cell layers the lateral ventricle; SVZ 
astocytes  are located adjacent to the ependymal cells. The immature cells 
derived from SVZ astrocytes are precursors for neuroblasts; this cells have 
stem cell features: self-renewal and give rise to transient amplifying 
precursors C cells that give rise to neuroblasts, which than differentiate into 
neurons. Also the astocytes in the SVZ can generate oligodendrocytes 
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(Doetsch et al., 2003, Mirescu et al., 2003, Temple et al., 2001). In this 
zone a specialized basal lamina extending from the blood vessels wrapped 
all types of cells (Fig. 13). 
 
                                  Fig.13: Neuronal stem cells niche in the SVZ zone: 
B are astocytes, E are ependymal cells, C are 
amplyfing cells and A are neuroblast. All types of 
cell are wraped by the basal lamina of the blood 
vessel (Li et al., 2005).    
 
 
 
 
The SUBGRANULAR ZONE (SGZ) is a zone in the hippocampus between 
the limbus and the dentate gyrus; in the SGZ the neurogenesis occurs 
directly with the contribution of blood vessels. The astrocytes act as stem 
cells able to  produce granule neurons (Fig.14) (Doetsch et al., 2003, 
Temple et al., 2001). 
 
Fig.14 : The SGZ neuronal stem cell niche: B are 
astrocytes directly attached to the blood vessels, D are 
proliferenting cells and G are differentiated cells into 
granule neurons.(Li et al., 2005) 
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In both zone (SVZ and SGZ), the blood vessel (endothelial cells and basal 
lamina) are principal components of the niche; these endothelial cells 
secreted signals and factors essential for control self-renewal and lineage 
commitment like BMP and their antagonists, WNT and β catenin, Noggin, 
FGF, IGF, VEGF, TGF α and BDNF (Shen et al., 2004, Doetsch et al., 
2003, Temple et al., 2001). 
 
2.5 THE HEART STEM CELL NICHE 
Recently, a new concept of niche was postulated for the heart. Urbanek et al 
in 2006 demonstrated the presence of a niche in the adult heart of the mice. 
The author demonstrated that this niche is present particularly in the atria 
and in the apex of the heart.  The Cardiac Niche is constituted by  Cardiac 
stem cells (CSC) and early lineage committed cells that are supported by 
similar cells found in the bone marrow and in the brain. Homeostasis of 
cardiac niche is mediated by asymmetric and symmetric division of CSCs. 
Different internal and external signals like Integrin, Numb, histone H3 , 
Connexins and Cadherin seem to be involved in the regulation of the niche 
in the heart (Urbanek et al., 2006) The presence of a stem cells niche in the 
human heart must be demonstrated yet. 
 
Taken together, the concept of stem cells niche presents in different adult 
tissue, could give important insights to identification of the stem cells niche 
in other systems, like in the vascular system, where isn‟t yet identified a 
complete understood niche. Further, in the concept of the niche, the blood 
vessels plays a fundamental role, therefore in the adult vessels would be 
reside stem cells and the other components that created a niche, in which 
the stem cells could be maintaining in a undifferentiated state and could be 
involved in the vessels homeostasis and turnover. 
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3. THE BLOOD VESSELS SYSTEM 
Blood vessels constitute the first organ in the embryo and form the largest 
network in the adult. There are three types of vessels - arteries, veins, and 
capillaries; they  are not anatomically the same and they are not just tubes 
through which the blood flows. Arteries have to expand to accept the blood 
being forced into them from the heart, and then squeeze this blood on to the 
veins when the heart relaxes. Arteries have the property of elasticity, 
meaning that they can expand to accept a volume of blood, then contract and 
squeeze back to their original size after the pressure is released. It is the 
elasticity of the arteries that maintains the pressure on the blood when the 
heart relaxes, and keeps it flowing forward. If the arteries did not have this 
property, the blood pressure would be more like 120/0, instead of the 120/80 
that is more normal. Arteries branch into arterioles as they get smaller. 
Arterioles eventually become capillaries, which are very thin and branching. 
It is in the capillaries that the exchange between the blood and the cells of the 
body takes place. Here the blood releases its oxygen and takes on carbon 
dioxide, except in the lungs, where the blood picks up oxygen and releases 
carbon dioxide. As the capillaries begin to thicken and merge, they become 
venules. Venules eventually become veins and head back to the heart. Veins 
do not have as many elastic fibers as arteries. Veins do have valves, which 
keep the blood from pooling and flowing back to the legs under the influence 
of gravity. When these valves break down, as often happens in older or 
inactive people, the blood flows back and pool in the legs. The result is 
varicose veins, which often appear as large purplish tubes in the lower legs. 
Capillaries are the smallest diameter vessels and the site of exchange of 
metabolites between blood and tissues. Capillaries consist of a single layer of 
endothelial cells and their basement membrane. The endothelial cells are 
joined together by tight junctions. At intervals, these tight junctions are 
interrupted, leaving small spaces allowing the passage of fluid  
(Pasqualino,1996). 
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3.1. HYSTOLOGY OF THE BLOOD VESSELS 
The blood vessels are made of three layers, called from the luminal side 
outward, the tunica intima, the tunica media and the tunica adventitia and the 
thickness of these three layers varies greatly depending upon the size and 
type of vessel (large, medium & small arteries and veins; capillaries).(Fig. 
15)(Gallegher, 1992). 
 
 
Fig. 15: The layers in the artery (intima, media, adventitial layer). a) 
Schematic representation; b) Hystology ( H&E). 
The tunica Intima:  
The intima is the inner layer of a vessel.  It  consists of  endothelium 
(present in all vessels) and subendothelial connective tissue may be present. 
The subendothelial layer is  highly variable, depending on the type of vessel 
and also  grows with age or disease conditions like arteriosclerosis. The 
endothelium of vessels entering or leaving the heart is continuous with that 
of the heart.  Both connective tissue and smooth muscle are present in the 
intima. The border of the intima, in the arteries, is delineated by the internal 
elastic lamina (elastic tissue) that forms the boundary between the intima 
and the media. Veins do not contain the elastic membrane lining that is 
found in arteries. In some veins the tunica intima layer also contains valves. 
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The tunica intima increases in thickness with age, and may also become 
expanded by lipid deposits, so the integrity is critical since damage can lead 
to atherosclerosis or clotting. 
The tunica Media 
The tunica media is the middle layer of arteries and veins wall. It is 
composed of smooth muscle and elastic fibers. This layer is thicker in 
arteries than in veins. The tunica media is the layer of concentrically-
arranged smooth muscle, the autonomic control of which can alter the 
diameter of the vessel and affect the blood pressure. Smooth muscle cells 
(in contrast to cardiac and skeletal) have secretory capabilities, and 
(depending on the vessel), the tunica media contains varying amounts of 
collagen fibres, elastic fibres, elastic lamellae, and proteoglycans secreted 
by the smooth muscle cells. The elastic tissue that forms the boundary 
between the media and the adventitial is called external elastic membrane.  
The tunica Adventitia 
The tunica adventitia is the strong outer covering of arteries and veins. It is 
composed of connective tissue as well as collagen and elastic fibres. These 
fibres allow the arteries and veins to stretch to prevent overexpansion due to 
the pressure that is exerted on the walls by blood flow. This adventitial 
connective tissue is usually more or less continuous with the stromal 
connective tissue of the organ in which the vessel is found.  The presence of 
adventitial connective tissue tightly adhering to vessels facilitates the 
surgical isolation and repair of vessels. It tends to be much larger in veins 
than arteries. Adventitia may also contain numerous elastic fibres. In the 
arteries with a diameter > 1 mm, blood vessels supplying the adventitia and 
outer media are also present, these are called vasa vasorum ("vessels of the 
vessels").  
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Arteries carry blood away from the heart. They are classified into three 
types according to their size: large or elastic arteries; medium (or muscular 
or distributive) arteries; and small arteries or arterioles, which are less than 
0.5 mm in diameter. The aorta is the largest artery in the body and principal 
artery of the body that carries oxygenated blood to most other arteries in the 
body. The aorta in humans rises from the left ventricle (lower chamber) of 
the heart, arches back and downward through the thorax, passes through the 
diaphragm into the abdomen, and divides into the right and left iliac arteries 
at about the level of the fourth lumbar vertebra. The aorta gives rise to the 
coronary arteries, which supply the heart muscle with blood, and to the 
innominate, subclavian, and carotid arteries, which supply the head and 
arms. The descending part of the aorta gives rise, in the thorax, to the 
intercostal arteries that branch in the body wall. In the abdomen it gives off 
the coeliac artery, which divides into the gastric, hepatic, and splenic 
arteries, which supply the stomach, liver, and spleen, respectively; the 
mesenteric arteries to the intestines; the renal arteries to the kidneys; and 
small branches to the body wall and to reproductive organs. The aorta is 
subject to a condition known as atherosclerosis, in which fat deposits attach 
to the aortic walls. If left untreated, this condition may lead to hypertension 
or to an aneurysm (a swelling of the vessel wall), which can be fatal 
(Pasqualino, 1996)(Fig.16). 
                         
 
 
 
 
Fig.16: The Aorta system 
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3.2. THE VASCULAR WALL AS A SOURCE OF STEM CELLS 
During the embryogenesis, the cardiovascular system is the first functioning 
developed apparatus, which requires coordinated development of the heart, 
the vessels and the blood and its function is critical for early embryo 
survival (Copp et al., 1995). First in 1920 Sambin proposed, in the vascular 
wall of the chick dorsal aorta,  the existence of a common progenitors cells , 
for endothelial cells and hematopoietic cells, called Hemangioblast (Sabin 
et al., 1920). When the blood islands are developed  in the yolk sac, 
haematopoietic and endothelial cells (ECs) are intimately related, so this 
association has prompted embryologists to assume the existence of a 
putative common ancestral progenitor. ECs and HSCs shared several 
markers and several genes like flk1, flt1, tie1, tie2, tal1 and Runx1 (Ema et 
al., 2003) .The clearest evidence for this common progenitors came from 
Choi and colleagues who found that differentiating embryonic stem cells 
contain blast-colony forming cells, which are able to generate both 
primitive hematopoietic and endothelial cells in appropriate conditions in 
vitro (Choi et al., 1998). In the intraembryonic aorta-gonad-mesonephros 
region (AGM), hematopoietic precursors can be seen as clumps of cells 
apparently budding off from the endothelial cells of the ventral wall of the 
dorsal aorta and the umbilical and vitelline arteries (Ema et al., 2003). 
Thus, during definitive as well as  primitive yolk sac haematopoiesis, there 
is a close association between endothelial and hematopoietic cells. In the 
postnatal life, the adult haematopoiesis take place in the bone marrow, 
where Hematopoietic stem cells reside in a special microenviromental or 
niche that promotes stem cells renewal and differentiation.  In has been 
showed that CD34+/KDR+ bone marrow cells, in mice and human, are 
enriched for endothelial precursors (Asahara et al., 1997, Peichev et al., 
2000) and single CD34+/KDR+ cells from adult bone marrow can generate 
both endothelial and hematopoietic cells in vitro. This studies raised the 
possibility of an adult hemangioblasts that might play a key role in normal 
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haematopoiesis and vessels turnover. In the 2002,  Minasi et al identified in 
the quail embryonic dorsal aortas the existence of a self-renewal, 
multipotent stem cell that expressed emo-angioblasts markers (CD34, C-kit, 
flk1) and that was able to differentiate in most mesodermal tissue 
(chondrogenic, osteogenic, adipogenic, skeletal muscle). The authors 
identified these vessels associated stem cells with the name of the meso-
angioblasts, on the assumption that it represents common progenitors for 
endothelial and other mesodermal cells, that participate in postembryonic 
development of the mesoderm (Minasi et al., 2002). Yet, the existence of 
mesangioblasts in adult tissue has not been reported. The process for the 
blood vessels formation during the early embryogenesis is called 
Vasculogenesis, i.e. represents the primary differentiation of endothelial 
cells from undifferentiated precursors cells called angioblasts. New vessels 
in the adult arise mainly through angiogenesis, a process defined as 
outgrowth of new vessels from preexisting blood vessels (Carmeliet, 2003). 
Recent studies indicate that postnatal vasculogenesis may occur indicating a 
role for circulating (C-EPCs) and/or bone marrow-derived endothelial 
precursor cells (BM-EPCs), cells with property of embryonal angioblasts,  
involved in the new blood vessel formation in response to various stimuli 
(Asahara et al., 1999a, Kalka et al., 2000, Pelosi et al.,2002). Once 
mobilized in the blood, EPCs are supposed to participate in physiological 
and pathological arterial wall remodeling during their lifetime (Carmeliet, 
2000, 2003), even if the homing and the contribute of EPCs for the 
formation of new vessels at the sites of ischemia have been demonstrated 
(Hristov et al.,2003), up to now the exact role of this cells in this site has 
been matter of debate (Asahara et al., 1999b, Bagley, et al.,2003,  
Carmeliet et al., 2001, Rajantie et al., 2004).   
Immature mesenchymal cells with vascular progenitor features have to been 
shown to reside in pheripheral tissue such as skeletal muscle, where they 
participate in angiogenesis after injury (Majka et al., 2003). In the last years 
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, some experimental evidences suggest that also the vascular wall is much 
more dynamic than ever before believed. In fact, apart from the 
unquestionable link with the hematopoietic system, some progenitors seem 
to be located within the adult vessel wall. Otherwise, the presence of 
ectopic tissue like cartilage , fat, muscle, bone and vascular tissue in the 
wall of diseases vessels is a common finding during routine 
histopathological observations. Several studies also indicated that putative 
smooth muscle  progenitor cells are present within the adult vasculature, 
and more precisely in the vascular adventitia (Liu et al 2004). In the last 
years, some experimental artherosclerosis studies demonstrated that the 
vascular adventitia could be implicated in neointimal proliferation. In 2004, 
Hu et al identified the presence of stem cell population in the vessel wall. In 
this study, the author isolated from the adventitia of mouse vessel wall, 
especially in the aortic root, a population of cells positive for Sca1+, cKit+, 
CD34+,FLK1+ and negative for the stage-specific embryonic antigen 1 
(SSEA-1). In primary culture this cells were heterogeneous, including 
fibroblast-like, rounded-shaped and adipocyte-like cells.  In order to 
characterize only the adventitial progenitor cells, the cells from primary 
culture, were sorted for Sca1.The Sca1 sorted cells resulted also C-kit+ and 
Lin-; they were able to differentiate into smooth muscle cells (SMCs) in 
vivo and ECs in vitro; they contributed to experimental atherosclerosis in 
vivo and also they did not originate from the bone marrow.  This study also 
suggested the abundant presence of resident progenitor cells in the aortic 
root respect others vascular areas demonstrating the embryological role of 
the aorta.(Hu et al., 2004). In according with this experimental evidence, 
afterwards it has been demonstrated that postnatal aorta contained an 
immature subpopulation of vascular progenitor cells, CD34+/ASMA-. 
These cells expressed markers of early pericyte lineage, had an 
undifferentiated ultrastructural morphology and  differentiated into mural 
cells in vitro but not into ECs (Howson et al., 2005). Ingram et al in 2005 
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showed that a complete hierarchy of EPCs can be identified also in mature 
endothelial cells such as human umbilical vein endothelial cells (HUVEC) 
and human aortic endothelial cells (HAEC) (Ingram et al,2005a). 
Otherwise, the human fetal aortas contained immature vascular progenitor 
cells (CD133+,CD34+, KDR+) coexpressing endothelial and myogenic 
markers in undifferentiated state, where as they can differentiate into ECs 
and muscular cells in vitro and secrete a complex combination of 
angiogenic factor that ameliorate ischemic tissue outcome in vivo (Invernici 
et al, 2007) This Vascular Progenitor Cells (VPCs) did not express CD45, 
indicating that may not arise from hematopoietic system but may derive 
from resident MSCs located in the niche of the fetal paraortic membrane or 
at the periphery of aorta wall parenchyma (Alessandri et al., 2001). In 2006, 
Zengin et al. suggested the existence of a vasculogenic zone in the adult 
human vascular wall located between the smooth muscle and the adventitial 
layer that contains vascular wall resident stem cells that could be serve as a 
reservoir of cells for postnatal vasculogenesis. This vasculogenic zone 
hypothetically contains cells of different subpopulations: vascular wall 
resident EPCs, that represents the first evidence of EPCs outside the bone 
marrow (Zengin et al., 2006), even if Ingram showed that vessel wall 
derived endothelial cells proliferate because they contain a complete 
hierarchy of EPCs (Ingram et al., 2005a) This zone may contain 
multipotent stem cells that are capable of differentiating into macrophage 
but probably also into hematopoietic progenitor cells (HPCs); theses cells 
could be a reservoir for inflammatory cells important for local immune 
response. In this study the author also hyphotized in the vasculogenic zone 
the presence of multipotent mesodermal stem cells that may serve as a 
precursors of SMCs, fibroblasts and perycyte (Zengin et al., 2006). 
According with this, several experimental observations shown that postnatal 
artery walls contain MSCs with multilineage differentiation. In 2003, Tintut 
et al described a subpopulation of vascular cells, isolated from bovine aortic 
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medial cells, called “Calcifying vascular cells”(CVC) that are able to 
differentiate in vitro along different mesenchymal lineages, e.g osteogenic, 
chondrogenic, leiomyogenic and stromogenic lineages, where as  the 
adipogenic potential of this cells was limited. CVCs, at flow cytometry 
analysis, were positive for surface markers commonly expressed by 
marrow-derived mesenchymal stem cells (positive for CD44 and CD29 , 
and  negative for hematopoietic markers like CD14 and CD45). Otherwise, 
CVCs replicated for 20-25 passages with retention of multipotentiality. 
Since these cells did not differentiate  toward adipogenyc lineage, they 
could represent a stage of commitment generation below the mesenchymal 
stem cells in the mesengenic hierarchy (Tintut et al., 2003). In another 
elegant study, Sainz et al in 2006 defined the possibility to isolate a “Side 
Population” (SP) of constitutively resident progenitor cells from healthy 
arteries of adult mice. In this study, living SP was found only in  the tunica 
media layer of  thoracic and abdominal aortas and their immunophenotype 
was Sca1+/Ckit 
-/low
 Lin
-
 with low CD34 and flk1 expression. Arterial SP 
cells did not express SMCs or ECs markers at the basal state but, in the 
presence of vascular endothelial growth factor (VEGF), differentiated into 
endothelial cells phenotype and when cultured on Matrigel showed 
vasculogenic potential, while, in the presence of TGF beta 1 or PDGF-BB, 
became more similar to SMCs phenotype. Arterial SP cells were unable to 
generate hematopoietic colonies on Methylcellulose, indicating no capacity 
of this cells to differentiate toward neither the myeloid lineage not the 
lymphoid  lineage. This cells could participate in arterial homeostasis and 
remodeling (Sainz et al., 2006). Furthermore MSCs isolated from the 
human saphena vein are able to differentiate in vitro into osteoblasts, 
chondrocytes and adipocytes (Covas et al., 2005). Recent observations 
demonstrated that  human vascular adventitia ( pulmonary arteries) contains 
mesenchymal stem/ progenitors cells ( Vimentina+, Cd29+, Cd44+, 
Cd105+ ,CD34-,Cd133-,CD14-,CD45-) with the capacity to differentiate in 
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vitro into adypocyes, osteoblsts, and myofibroblasts. (Hoshino et al., 2008). 
Taken together these experimental evidences suggest the presence of 
resident stem cells ( multipotent or a mixture of committed progenitors 
cells) within the postnatal arterial wall, which are involved in the postnatal 
vasculogenis and in the formation of ectopic tissue. Adult stem cells in the 
vessels seem to be located in the vasculogenic zone between the media and 
the adventitial layer. Even so, the definition of a functional 
microenvironment (niche) in the human postnatal  vessels, where stem cell 
related to mouse and chicken mesoangioblast can be maintained in a 
quiescent state, must be determinate. 
3.3 ANGIOGENESIS 
Vessels formation occurs mainly through two mechanisms: Vasculogenesis 
and Angiogenesis. Vasculogenesis represents de novo formation of blood 
vessels during embryonic development. Mesoderm-derived stem cells 
(hemangioblasts) form aggregates (blood islands), and they develop into 
primitive hematopoietic and endothelial cells (angioblasts). The angioblasts, 
undifferentiated precursor cells, proliferated and differentiated in situ into 
endothelial cells to form a vascular labyrinth (Carmeliet, 2000). In postnatal 
life adult hemangioblasts seemed to be present even if their location and 
characterization must be determinate. On the other hand, the formation of 
new vessels from preexisting vessels is called angiogenesis. New vessels in 
the adult arise mainly through angiogenesis, although vasculogenesis also 
may occur. Angiogenesis is a tightly regulated process required for a 
number of physiological process like wound healing, ovulation and 
menstruation as well as embryonic development. Excessive angiogenesis is 
seen in a wide range of diseases including tumors, inflammatory diseases 
and diabetic retinopathy (Kiumura et al., 2003). Angiogenesis is a very 
complex mechanism that include different steps. Angiogenesis initiates with 
vasodilation, a process involving nitric oxide. This increase in permeability 
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lead to a preexisting vessel destabilization and loss of the endothelial cell 
interactions. Different angiogenic growth factors are released. These 
molecules lead to matrix metallo proteinase activation, crucial for 
extracellular matrix degradation. After this, endothelial cells proliferate and 
migrate to assemble in a  solid cords that subsequently acquire a lumen. 
Subsequently, pericytes and SMCs migrate in order to reorganize the 
cellular interactions and surround the new formed vessels. Angiogenic 
sprouting is controlled by a balance of activators and inhibitors. Important 
activator factors are VEGF (vascular endothelial growth factor), FGF 
(fibroblast growth factor), TGF-β (transforming growth factor β), IL-8 
(interleukin 8) and Angiopoietin-I. Inhibitors factors are Interferon α, β, γ, 
IL-12 (interleukin 12), Angiostatin and Endostatin (Carmeliet, 2000).  
3.3.1 VASCULAR ENDOTHELIAL GROWTH FACTOR 
The family of VEGF includes VEGF-A, B, C, D and placenta growth 
factor. VEGF (denoted as VEGF-A) was initially named vascular 
permeability factor for its ability to induce vascular permeability. Later this 
vascular endothelial specific mitogen was named VEGF for  its ability to 
promote proliferation of   endothelial cells. VEGF play a key role during 
angiogenesis process as activator. VEGF induces endothelial cells 
proliferation, migration differentiation and survival. Knock-out experiments 
have demonstrated that heterozygous VEGF-A knout-out mice were 
embryologically lethal and that blood vessels formation was dramatically 
impaired (Ferrara, 1996). The main receptors which seem to initiate signal 
transduction cascades in response to VEGF binding consist of three kinds of 
tyrosine kinases : VEGF-R1 or Flt1 (fms-like tyrosine-kinase 1), VEGF-R2 
or KDR (kinase-insert domain receptor) and VEGF-R3 or Flt3(fms-like 
tyrosine-kinase 3). Among them, KDR may mediate the major action on 
cell growth and permeability. (Gale et al., 1999). Different factors have 
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been found to induce VEGF expression like hypoxia, cytokines, growth 
factors. 
3.3.2 MSC and ANGIOGENIC DIFFERENTIATION 
As above described, endothelial and hematopoietic cells share a common 
progenitor : the hemangioblast, a cell derive from embryonal mesoderm. 
Today, the more reliable hypothesis is that hemangioblast derived from 
mesenchymal stem cells. However, it must be determinate if adult 
mesenchymal stem cells maintained this differentiation capacity. Reyes et 
al. in 2002 isolated from adult bone marrow a multipotent population of 
adult stem cells, called MAPC (multipotent adult progenitors cells), able to 
differentiate into endothelial cells and other mesodermal tissues. These cells 
were negative for endothelial markers like CD34, VE-Cadherin (vascular 
endothelial cadherin), AC133 and Flk1( fetal liver kinase) and can 
differentiate in vitro into mature endothelial cells (Reyes et al., 2002). 
Recent studies demonstrated that also adult mesenchymal stem cells are 
able to differentiate in vitro into endothelial cells. In 2003, Annabi et al 
suggested that hypossic culture conditions (1% O2, 5% CO2, 94%N2) 
induced mouse BM-MSC migration and tree-dimensional capillary like 
structures formations on Matrigel (Annabi et al., 2003). Further, Oswald et 
al. showed that human BM-MSC are able to differentiate into cells with 
phenotypic (vWF, KDR,FLT) and functional (capillary like structures on 
Matrigel) features of endothelial cells when cultivated under confluence, 
presence of 2% of fetal calf serum (FCS) and 50 ng/ml VEGF for 7 days at 
37°C-5% CO2.(Oswald et al., 2004). Moreover, Alviano et al. demonstrated 
that human MSCs from amniotic membrane (AM-hMSCs) spontaneously 
form capillary-like structures when cultured in Matrigel. This behavior has 
been enhanced by the presence of VEGF containing culture medium, and 
the endothelial committement of the cells was demonstrated by the 
expression of von Willebrand factor (Alviano et al., 2007). 
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3.4 THE VASCULAR TISSUE BANKING 
In the 1990, due for the increasing demand of vascular homografts used in 
the vascular surgery like for prothesic infections, peripheral arterial 
occlusive disease or abdominal aortic aneurysm , raised  in Europe the 
establishment of Cardiovascular tissue Banking, where the vascular 
homografts from multiorgan donors are procured, prepared, cryopreserved 
and distributed. Emilia Romagna Cardiovascular Tissue Banking is located 
in Bologna, S.Orsola-Malpighi Hospital, and it is certified ISO 9000 from 
2003; so all the procedures, included the setting standards for quality and 
safety for the donation, procurement, testing, processing, storage and 
distribution, followed the “ Directive of the European Parliament and of the 
Council” ( 28-05-2003).  The vascular homografts were harvested by a 
vascular surgery team in brain-dead multiorgan donors. The principal 
criteria for the baking of the vessels are: age 15-55 years, absence of 
cardiovascular disease, negativity for HIV, Hepatitis B and C, Treponema 
Pallidum, CMV and Toxoplasma.  Harvested vessels were kept in a sterile 
boxes with RPMI or Celsior Media and transferred in a isothermal boxes 
filled with ice to the Cardiovascular Tissue Bank. Under a laminar flow, a 
specialized vascular surgery team prepared and classified the samples in 
according to the quality of the tissue. For arterial vessels: 
Class III: Good gross morphology, only small lipid streaks, pressure test 
positive.  
Class II: Focal intimal thickennings; fibrocalcific plaques without evidence 
of hemorraghe and / or intimal ulcer (<15%),  
Class I : Enlarged wall (aneurysm), presence of mural calcification ( 
>30%), intimal ulcer,  pressure test negative 
After preparation , the samples were transferred in an antibiotic solution for 
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72 h at 4°C, and successively transferred in a sterile bags containing  the 
cryosolution ( RPMI plus human albumin and DMSO at the concentrations 
of 10% as a cryoprotectant), cryopreserved in a programmable freezer ( 
cooling rate of -1°C/min to -120°C) and stored, with a specific barcode for 
the identification, in the vapor phase of liquid nitrogen at -140°C ( not more 
of 5 years). Microbiology tests were performed before and after 
decontamination ( aerobic and anaerobic bacteria, fungi); positive serology 
and persistent positive microbiology after decontamination were criteria for 
rejection. A small pieces of tissue were fixed in formalin-buffered for the 
histology examination. When the vessels were requested, the cryopreserved 
homograft were sent in dry ice to the hospital with the thawing protocol 
included. The bags , in which the sample were stored, were quickly 
submerged in a water bath at 39°C and let thaw for 10 min. When thawing 
was achieved, the bags were cut under sterile conditions and the samples 
were washed in cooled saline solution ( NaCl 0.9%) for 3 times to remove 
the cryoprotectant that may be toxic at temperature above 10°C. (Buzzi et 
al, 2005). 
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4. AIM OF THE WORK 
 
Stem cells are one of the most fascinating areas of biology today, and  in 
particular, in the last years, Adult Stem Cells  have generated much interest 
especially for their application potential as source for cell based 
regenerative medicine and tissue engineering. Adult stem cells have been 
found in different tissues like bone marrow, skin, intestine, nervous system, 
where they reside in a special microenviromental termed “Niche”. For this 
reason, scientists have tried (attempted) to identify and discover Adult stem 
cells in different organ and tissue, where they may play a primary role to 
maintaining and repairing the tissue. The arterial wall of the blood vessels is 
much more plastic than ever before believed. Several studies demonstrated 
that some progenitor cells seem to be located within the adult vessels. 
Resident vascular progenitor cells have been isolated from different vessel  
territories: thoracic and abdominal aortas of healthy adult mice (Sainz et al., 
2006); human internal thoracic arteries (Zenging et al., 2006); adventitia of  
apoE-deficient mouse aortic root (Hu et al., 2004); human and quail dorsal 
aortas(Invernici et al., 2007, Minasi et al.,2002) . Recently, Zenging et al 
have postulated the presence of  a “vasculogenic zone” in human adult 
arteries in which a complete hierarchy of resident stem cells were nicked in 
the arterial walls. Moreover, the authors hypothesized the presence of adult 
vascular wall- resident Mesenchymal stem cells, that  have the ability to 
differentiate in smooth muscle cells, in surrounding pericytes and 
fibroblasts. (Fig. 17) (Zengin et al., 2006). 
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Fig. 17: Hypothetical scheme of the “ Vasculogenic zone” in the arterial 
wall (Zengin et al., 2006) 
 
 
Thanks to a collaboration with Cardiovascular Tissue Bank, that 
cryopreserved human vessels for arterial reconstructive surgery, the present 
work aimed to identify in situ and isolate adult stem cells (MSCs) from 
thoracic aortas of young and healthy heart-beating multiorgan donors. 
Further, because the clinical therapeutic approaches based on EPCs is 
hampered by difficulties in obtaining an adequate number of functional 
progenitors, this study aimed to establish whether MSCs from human 
thoracic aortas can be differentiate in vitro in endothelial cells.  
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5. MATERIALS AND METHODS 
5.1 HUMAN ARTERIAL SAMPLE 
Working in collaboration with the Cardiovascular Tissue Bank, Service of 
Transfusion Medicine, Policlinico S. Orsola- Malpighi, Bologna, Italy, we 
included in the present study human vessels ( human thoracic aortas and 
human femoral arteries) harvested from  multi-organs donors , which, if 
were considered suitable for arterial reconstructive surgery by a vascular 
medical team, were cryopreserved and then used in the common vascular 
surgery like a homograft.  The requirement to define this are: age between 
15-55 years, absence of cardiovascular disease, negativity for virological 
tests (HIV, Hepatitis B and C, Treponema Pallidum, CMV,Toxoplasma), 
negativity for microbiological tests for bacteria and fungi, quality of the 
tissue (Class III: perfect, Class II: lesser quality but still acceptable, class I: 
discarded) (Buzzi et al., 2005). 
 
5.2 PROCEDURES OF ARTERIAL SAMPLE 
CRYOPRESERVATION 
After collection, the human vessels were kept in a sterile box with Celsior 
Media (IMTIX SANGSTAT, Lyon France), a flushing and cold storage 
solution for solid organ preservation, and transferred to the Cardiovascular 
tissue Banking in isothermal boxes filled with ice within 1 hour since 
procurement. Under a sterile conditions, e.g. a laminar flow in a sterile 
hood, the arteries were prepared, classified and transferred to a solution 
composed with RPMI 1640 (Cambrex Bioscience Vierviers, Belgium) plus 
antibiotics according to Strickett et al (Strickett et al, 1983). The medium 
was completed with a mixture of Mefoxin 240 mg/ml, Lincomycin 
120mg/ml, Colimycin 100 mg/ml, and Vancomycin 50 mg/ml while 
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Amphotericin B was not included because her potential tissue tossicity. 
After decontamination in this medium for 72 h at 4°C , the samples were 
transferred into a sterile bags containing a fresh cryoprotectant solution 
RPMI 1640 with human albumin (Kendrion, Lucca, Italy) and Me2SO4 at a 
final concentration of 10%, that was before cooled at 4°C for 30 min. The 
bags were kept at 4°C for 30 min to allow the Me2SO4 to penetrate into the 
tissue completely. The bags were labeled and cryopreserved in liquid 
nitrogen vapor in a controlled rate freezing system (IceCube 1860, Sy-Lab, 
Wien, Austria) using an electronically monitored programs that allow to 
decrease the temperature at 1°C/min to – 45°C and at the faster rate 
thereafter until – 120°C has been achieved. The cryopreserved arterial 
homografts were stored in the vapor phase of liquid nitrogen ( - 196°C). 
Each freezing curve was checked and validated in the laboratory 
(Pasquinelli et al., 2006 ). 
 
5.3 PROCEDURES OF ARTERIAL SAMPLES THAWING 
Human arterial samples were thawed as followed (based on the methods 
routinely used for reconstructive vascular surgery): the bags, in which the 
sample were stored, were quickly submerged in a water bath at 39°C and let 
thaw for 10 min. When thawing was achieved, the bags were cut under 
sterile conditions and the sample were washed in cooled saline solution 
(NaCl 0.9%) for 3 times to remove the cryoprotectant that may be toxic at 
temperature above 10°C (Pasquinelli et al.,2006). 
 
5.4 FRESH AND CRYOPRESERVED ARTERIAL TISSUE: 
HISTOLOGY ANALISYS 
A single pieces of a 1 cm long ring of each arterial sample before and after 
cryopreservation procedures was fixed in 10% buffered formalin, the gold 
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standard of fixatives for routine histology and immunohistochemistry. 
Fixation of tissues is necessary to 1) adequately preserve cellular 
components, including soluble and structural proteins; 2) prevent autolysis 
and displacement of cell constituents, including Ags and enzymes; 3) 
stabilize cellular materials against deleterious effects of subsequent 
procedures; and 4) facilitate conventional staining and immunostaining. 
Formaldehyde preserves mainly peptides and the general structure of 
cellular organelles. It also interacts with nucleic acids but has little effect on 
carbohydrates. It is a good preservative of lipids if the fixative contains 
calcium. In solution, formaldehyde is capable of binding the following 
amino acids: lysine, tyrosine, asparagines, histidine, arginine, cysteine, and 
glutamine. The basic mechanism of fixation with formaldehyde is the 
formation of addition products between the formalin and uncharged reactive 
amino groups (–NH or NH2), forming cross-links (Ramos et al., 2005). 
After fixation, the sample was washed , dehydrated in a gradual series of 
alcohol(3x5min each), waxed in xilene( 2x 15 min each) and then 
embedded in paraffin (2x30 min at 4°C); then 5 µm thick sections, obtained 
at the microtome, were stained with haematoxylin and eosin according to 
the histology procedures. The slide were then observed under a light 
microscopy (Olympus CX42).connected with a CCD Camera to obtain 
images. 
 
5.5 FRESH AND CRYOPRESERVED ARTERIAL TISSUE : TEM 
ANALYSIS 
For Trasmission electron microscopy (TEM) analysis, human arterial 
specimens before and after cryopreservation were fixed in 2.5% 
glutaraldehyde in Phosphate Buffer 0.2 M over night at 4°C. Following 
washing in Phosphate Buffer 0.15 M, the samples were post-fixed in 1% 
Osmium Tetroxide in Phosphate Buffer 0.1 M for 1 hour at RT. After 
dehydration through increased concentration of ethanol (3x10 min each at 
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RT), the sample were immersed in polypropylene oxide (2x15 min at RT)  
and then embedded in a epoxy resin (50% Araldite CY212 + 50% Araldite 
HY + 1.5 % of accelerator, Benzyldimetylammina (BDMA) (all purchased 
from TAAB, England). Semi thin section obtained with ultramicrotome 
were stained with toluidine blue, while ultrathin sections were stained with 
uranyl acetate and lead citrate and then examined in a transmission electron 
microscopy Philips 400 T (Pasquinelli et al., 2006 ). 
 
5.6IN SITU CELL PRESERVATION: 
IMMUNOHISTOCHEMISTRY PROTOCOL 
For the evaluation of in situ cell preservation, formalin fixed paraffin-
embedded 5 µm thick sections of the arterial sample before and after 
cryopreservation were stained for the immunohistochemistry (IHC) 
protocol. IHC was performed by using monoclonal antibodies against CD34 
(clone QBend-10, dilution 1:80, Dako, Copenhagen, Denmark) to detect 
endothelial cells and monoclonal antibodies against smooth muscle actin 
(ASMA, clone 1A4, dilution 1:8000, Dako, Copenhagen, Denmark) to 
detect smooth muscle cells. In brief, the sections were dewaxed with xilene 
and rehydrated through decreasing concentrations of ethanol. Endogenous 
peroxidase was blocked by 10 min incubation at room temperature (RT) 
with absolute methanol containing 1.5% H2O2. Because fixation modifies 
the tertiary structure of proteins (Ags), many times making them undetected 
by specific Abs so antigen retrieval is necessary. To recover tissue 
antigenicity, the slides were put in Citrate Buffer ph 6 and then used a heat-
based retrieval (120°C, 20 min., 1 atm :autoclave cycle). After cooling the 
slides at RT for 20 min and following several washes, section were 
incubated with primary antibody, above mentioned, diluted with PBS-1% 
BSA in a humidified chamber at 4°C over night (o.n.). Following washing, 
sections were incubated with a byotinylated antibody, affinity purified 
horse anti-mouse secondary antibody (Vector Laboratories, dilution 1:500 
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in PBS-1% BSA, Burlingame, CA, USA) for 30 min at RT and then with 
streptavidin:biotinylated peroxidase complexes (Biospa-Division, dilution 
1:250 in PBS-1% BSA, Milano, Italy) for 30 min at RT and finally treated 
with diaminobenzidine (Sigma- Aldrich) in solution with H2O2 for 5 min at 
the dark. The reactions was stopped in distillated water and then the slides 
were counterstained with hematoxylin, dehydrated through increased 
concentration of ethanol, waxed in xilene, permanent mounted (Canada 
Balsam, Sigma, Milano, Italy) and then observed by light microscopy 
(LM)(Olympus CX42) (Pasquinelli et al., 2006 ). 
 
5.7 IN SITU CELL DEATH: TUNEL ASSAY 
Apoptotic cells on arterial samples before and after cryopreservation 
procedures were end –labeled in situ by TUNEL( Terminal 
deoxynucleotidyl transferase-mediated dUTP nick-end labeling) staining 
using  “ In situ Cell Death Detection Kit- POD” (Roche Applied 
Biosciences, Germany) according to the manufacturer‟s instructions. In 
brief, the slide were dewaxed in xilene and then rehydrated through a 
decreasing concentration of ethanol and distillated water. Endogenous 
peroxidase was blocked incubating the slide in a solution of 3% H2O2 in 
Methanol, for 5 min at the dark following washing in distillated water. To 
recover the tissue antigenicity, the sample were digested with a solution of 
Proteinase K (20 µg/ml PK in 10 ml Tris/HCl, pH 7.4, Roche Applied 
Biosciences Germany) for 30 min at 37°C. After several washing in PBS, 
50 µl TUNEL REACTION MIX diluted 1:5 with Tunel dilution Buffer 
(Roche Applied Biosciences, Germany) for slides were used and then the 
samples were incubated in a humidified chamber for 60 min at 37°C at the 
dark. The TUNEL REACTION MIX diluted 1:5 was done, in ice, as 
following: 
5 µl of Enzyme Solution + 20 µl of Tunel Buffer to make dilution 1:5 
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5 µl of the Enzyme Solution 1:5 + 45 µl of Label Solution  
Two controls, positive and negative, were included in each experimental set 
up. Negative control was done incubating the sample only with 50 µl of 
Label Solution without the enzyme terminal transferase, while the positive 
control was done incubating with DNase I, grade I for 10 min at RT to 
induce DNA strand breaks, prior to labeling procedures with Tunel reaction 
Mix. After three washing in PBS, the slides were incubated with 50 µl of 
CONVERTED POD for 30 min at 37°C in a humidified chamber and 
finally treated with diaminobenzidine (Sigma- Aldrich) in a solution with 
H2O2 for 5 min at the dark. After washing in PBS, the slides were 
counterstained with hematoxylin, dehydrated, waxed in xilene and then 
mounted for the analysis by light microscope (Olympus CX42) (Pasquinelli 
et al., 2006 ). 
 
5.8 ISOLATION CELLS FROM CRYOPRESERVED ALLOGRAFTS 
Cells were obtained from cryopreserved allografts by scraping and by 
enzymatic digestion. Briefly, the samples were treated with type VII 
collagenase (0.1% Sigma-Aldrich) and scraped until reaching the 
adventitial layer. Minced tissue was incubated with the same concentrations 
of collagenase at 37°C in 5% CO2 humidified atmosphere for 1 h. Then , 
cells isolated were filtered, centrifuged in Hepes Buffer, pH 7.4 , plus FBS 
10 % (Seromed, Biochrom KG, Berlin, Germany) for 5 min 2x at 1800 rpm 
and then the pellets were suspended in 2 ml of PBS for Flow cytometry 
analysis (Pasquinelli et al., 2006). 
 
5.9 FLOW CYTOMETRY ANALYSIS 
Flow cytometry was used to assess in vivo cell viability and to establish the 
phenotype of cells from cryopreserved allografts. Cell viability was 
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performed as follows: to 5 x10
5
 cells in 2 ml volume of PBS, 20 ml 7 –
amminoactinomycin D (7 ADD)  solution (Beckman-Coulter, Miami FL, 
USA) were added; after 20 min of incubation the cells were analyzed with a 
FC 500 Flow Cytometer (Beckman-Coulter). To analyze CD34 expression, 
5x10
5
 cells in a 100 ml volume of PBS were incubated for 20 min with 20 
ml of CD34-PE (Beckman-Coulter). ASMA analysis was performed by 
intracytoplasmic stain. Briefly, cells were fixed with reagent 1 of the 
Intraprep kit (Beckman-Coulter) following manufacturer‟s instruction. 
After two washes with PBS, the samples were permeabilized with reagent 2 
and, after two additional washes, cells were first incubated with 5ml of 
ASMA (Sigma–Aldrich) and, subsequently, with FITC anti-Mouse IgG 
(Beckman-Coulter). Control samples were run with an irrelevant 
monoclonal antibody and FITC anti-mouse IgG. (Pasquinelli et al., 2006) 
 
5.10 ORGAN CULTURE: LM AND TEM 
Organ culture was used to establish the ability of cells to recover 
freezing/thawing injury. The samples were carefully placed in contact with 
the 100mm culture plates. RPMI 1640 with L-Glutamine (Cambrex, 
BioScience, Vierviers, Belgium), 10% FCS (Seromed, Biochrom KG, 
Berlin, Germany) and 1% Penicillin/Streptomycin 100X solution 
(EuroClone, Life Science Division, Milano, Italy) was added. The culture 
plates were placed in a 37 °C incubator with 5% CO2. After culturing for 4, 
8, and 15 days tissues were processed for LM and TEM as described above 
( for LM see paragraph 5.4, for TEM analysis see paragraph 
5.5)(Pasquinelli et al., 2006).  
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5.11 ANTIGENICITY PRESERVATION : 
IMMUNOHISTOCHEMICAL STAINING FOR HC-10 E NAMB-1: 
To detect if the cryopreservation procedures can modify arterial homograft 
antigenicity, we performed a immunohistochemical study of fresh and 
cryopreserved human arteries to visualize the expression of HLA class I 
heavy and light chains “ in situ” by using the HC-10 and Namb-1 
monoclonal antibodies.  The HC-10 and Namb-1 MoAbs were generated, 
purified and characterized as described elsewhere (Perosa et al. 2003; 
Pellegrino et al. 1982; Stam et al. 1986). The HC-10 antibody recognizes 
an epitope expressed on virtually all b2-microglobulin- free HLA-B heavy 
chains and on b2-microglobulin-free HLA-A10, HLA-A28, HLA-A29, 
HLA-A30, HLA-A31, HLA-A32 and HLA-A33 heavy chains. The Namb-1 
antibody recognizes both free and HLA class I heavy chain-associated 
human b2-microglobulin. About 5-µm sections from fresh and 
cryopreserved arterial segments were dewaxed with xylene and rehydrated 
through decreasing concentrations of ethanol. Endogenous peroxidase 
activity was blocked by a 20-min incubation at RT with absolute methanol 
containing 1.5% H2O2. To recover tissue antigenicity, tissue sections were 
immersed in a jar containing a Tris/HCl EDTA buffer (pH 9) and treated at 
98 °C in a water bath for 20 min. After rinsing in PBS (pH 7.4) tissue 
sections were incubated with HC-10 (1:600) and Namb-1 (1:50) MoAbs in 
a humidified chamber overnight at room temperature. Monoclonal antibody 
tissue labeling was revealed by using a non-biotin polymeric system 
(BioGenex Super Sensitive TM Polymer-HRP IHC Detection System, 
Biogenex, San Ramon, CA). Briefly, tissue sections were treated with the 
Super Enhancer TM Reagent for 20 min at RT , washed in PBS and 
incubated with SS-HRP polymeric complexes for 30 min at RT. After 
several washings in PBS, peroxidase activity was detected by incubating 
tissue sections for 2–3 min with a freshly prepared solution of 3,3‟-
diaminobenzidine (Sigma Chemicals Co., St. Louis, MO; 40 mg of 3,3‟-
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diaminobenzidine in 100 ml of PBS containing 100 µl of H2O2). Tissue 
sections were counterstained with Mayer‟s haematoxylin (Sigma 
Chemicals), dehydrated through increased concentration of ethanol, waxed 
in xilene and then permanent mounted (Canada Balsam, Sigma, Milano, 
Italy). Negative controls were done by omitting incubation with the primary 
antibody. Tissue sections were read independently by two investigators. 
Endothelial cells from venous, arterial and capillary vessels from samples 
of normal human ovarian cortex were considered as positive controls 
(Pasquinelli et al., 2007 a). 
 
5.12 IDENTIFICATION IN SITU OF A “VASCULOGENIC ZONE”: 
IMMUNOHISTOCHEMICAL STUDIES:  
Fresh thoracic aortas and femoral arteries were harvested from 10 heart-
beating multi-organ donors (mean age 32 years); after procurement and 
decontamination arterial samples were routinely processed for histological 
examination. Details of the procurement and sampling procedures are 
reported elsewhere (see paragraph 5.1 and 5.4). The immunohistochemical 
staining here used was similar to that described previously (see paragraph 
5.6). Five μm-thick sections from formalin-fixed, paraffin embedded 
arteries were stained with the monoclonal antibodies (MoAbs) listed below: 
c-kit (CD117, 1:200, DakoCytomation, Hamburg, Germany), CD34 (1:80, 
DakoCytomation), von Willebrand Factor (vWF, 1:50, DakoCytomation), 
CD45 (1:120, DakoCytomation), S-100 ( 1:5000, DakoCytomation, 
Hamburg, Germany), CD68 (1:200, DakoCytomation, Hamburg, Germany) 
and ki-67 (1:200, Novocastra, Newcastle upon Tyne, United Kingdom).  
To detect the antigen-antibody reaction, the strept-ABC complex/HRP duet 
technique was used followed by diaminobenzidine tetrahydrochloride as a 
substrate solution (DAB, Sigma, Milan, Italy). Negative controls were 
performed by omitting the primary antibodies. The immunohistochemical 
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reactions were then observed under a light microscopy (Olympus CX42) 
with the software Image proPlus, connected with a CCD camera 
(Pasquinelli et al., 2007 b). 
5.13 ISOLATION AND ESPANSION OF ADULT STEM CELLS 
FROM FRESH HUMAN THORACIC AORTAS 
Human thoracic aortas were harvested from  multi-organ donors (n°. 10; 
mean age 32 years) kept at the Cardiovascular tissue Bank, Policlinico S. 
Orsola- Malpighi, that weren‟t considered suitable for cryopreservation and 
then for the use in arterial reconstructive surgery. Approximately 5 cm-long 
samples were used for isolation of a putative population of stem cells 
resident in the vascular wall. The arterial samples after 72 h of 
decontamination in a sterile solution of RPMI 1640 plus antibiotics 
(Pasquinelli et al., 2006 a), under sterile conditions,  were cut, 
longitudinally opened, providing an exposed surface area measuring about 
25-30 cm
2
, and then washed with sterile Hepes Buffer. The harvested pieces 
of arterial tissue were mechanically minced with a scraper until reaching the 
adventitial layer and enzymatically digested with 0.1% collagenase type II 
(Sigma, Milan, Italy) in Hepes Buffer for 30 min at RT (Fig. 18).  
 
 
Fig. 18:  Mechanics scraper (a) and enzymatic digestion (b) of arterial 
sample 
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Minced tissue  was subsequently incubated with the same concentrations of 
collagenase at 37°C in a 5% CO2 humidified atmosphere for other 30 min. 
The homogenate was subsequently filtered, centrifuged in Hepes Buffer , 
pH 7.4 plus 10 % fetal bovine serum (FBS) to block the action of 
Collagenase. The pellets  were washed twice in PBS; the cells were then 
counted and plated at 1x10
6
/cm
2
 in collagen biocoated culture flasks (BD 
Labware, Franklin Lakes, NJ) in Dulbecco‟s Modified Eagle‟s Medium 
(DMEM) supplemented with 20% heat inactivated FBS and antibiotics (100 
U/ml penicillin and 100 μg/ml streptomycin), and incubated at 37 °C in a 
humidified atmosphere with 5% CO2. The overall number of mononuclear 
cells recovered from each isolation varied from 1.5 x 10
6
 to 3.5 x 10
6
. After 
one week the non-adherent cells were removed by replacing the medium 
supplemented by 10% FBS. After plating, the cells yielded by the primary 
culture ranged between 0.5 to 1 x10
6
. When the cultures were near 
confluence (approximately 1-2 weeks) the cells were detached by treatment 
with 0.25% trypsin-EDTA (Sigma) and were maintained and subcultured 
for up to 12-15 passages (Pasquinelli et al., 2007 b). 
 
5.14 IMMUNOPHENOTYPING: FLOW CYTOMETRY ANALYSIS 
Flow cytometry was used to establish the immunophenotype of cells 
isolated from fresh human thoracic aortas. Cells taken at passages 3-5 were 
washed twice with PBS containing 2% fetal bovine serum (FBS) and 
stained for 20 min at RT using the following MoAbs: CD133-PE (Miltenyi 
Biotech, Bologna, Italy), CD117-FITC, CD34-PE, CD44-FITC, CD90(Thy-
1.2)-PC5, CD105-PE, CD166-PE, CD45-APC, CD146-PE, HLA class I-
FITC, HLADR- FITC all from Beckman-Coulter (Beckman-Coulter, Milan, 
Italy). Because the MSCs from bone marrow are identified for the 
coexpression of three markers like CD44, CD90, CD105, to study this 
immunophenotype, the cells were simultaneously incubated with CD105-
PE, CD44-FITC and CD90(Thy-1.2)-PC5 MoAbs (Beckman-Coulter). 
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Negative control samples were run with an appropriate conjugated 
irrelevant monoclonal antibody . Samples were analyzed using a Cytomics 
FC500 Flow Cytometer equipped with two lasers for data acquisition 
(Beckman-Coulter). Results were analyzed using the CXP Software 
(Beckman-Coulter) (Pasquinelli et al., 2007 b). 
 
5.15 IMMUNOFLUORESCENCE ANALYSIS 
For parallel immunofluorescence analysis, the fibroblast-like cells obtained 
from fresh human thoracic aortas were harvested at the same point of 
culture for flow cytometry analysis  by treatment with 0.05% trypsin-EDTA 
and then plated at 1x10
3
/cm
2
 in collagen biocoated slide chambers (BD 
Biosciences, Franklin Lake, NJ) and then cultured until near confluence. 
The samples were then fixed in  2% paraformaldehyde in PBS for 4 min. at 
RT while to detect intracytoplasmatic protein, 0.01% Triton X-100 was 
added during the fixation. Unspecific staining were blocked incubating the 
cells with a solution of 1% BSA (Bovine Serum Albumine) in PBS for 30 
min at RT in a humidified chamber. After this, the blocking solution was 
carefully removed and then the cells were incubated for 45 min at 37 °C in 
a humidified chamber with the following Monoclonal antibodies: CD44 
(1:50, BD Pharmigen, Milan, Italy), CD90 (1:50, BD Pharmigen), CD105 
(1:10, BD Pharmigen), CD166 (1:20, BD Pharmigen), ASMA (1:9000, 
Sigma) and CD45 (1:120, DakoCytomation). Following several washing in 
PBS (n. 3), the samples were incubated for 60 min at 37° C with FITC-
conjugated polyclonal rabbit anti-mouse immunoglobulins (1:250, 
DakoCytomation, Germany). After this incubation time, the cells were 
washed several times with PBS to remove the secondary antibodies 
unlabeled and then the samples were mounted and nuclei counterstained 
with a commercial kit “Pro long antifade reagent with DAPI” (Molecular 
Probes, Milan, Italy). Negative controls were done by omitting the primary 
antibodies. Samples were observed under a fluorescence microscope 
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(Axiovert 40, Carl Zeiss) connected with a CCD camera to performed 
imagines (Pasquinelli et al., 2007 b). 
 
5.16 ULTRASTRUCTURAL ANALYSIS OF CELL : TEM 
ANALYSIS 
For a ultrastructural studies, the cells, at 3-5 passages, were washed with 
phosphate-buffered 0.15 M, fixed directly in the culture flasks with 2.5% 
phosphate-buffered glutaraldehyde for 10 min at RT and then scraped, 
collected in a eppendorf tube and centrifuged for 10 min at 1800 rpm. The 
pellets were then fixed in 2.5% phosphate-buffered glutaraldehyde for 24 
hours at 4°C, and then processed with the same protocol described before 
for transmission electron microscopy (see paragraph 5.5). The results 
obtained were compared with the features we found in a study in which we 
compared the ultrastructural characteristics of mesenchymal stem cells from 
human bone marrow and term placenta (Pasquinelli et al., 2007 c).   
 
5.17 STEM CELLS mRNAs EXPRESSION by RT- PCR 
Total RNA was extracted from cells at 3-5 passages isolated from human 
fresh aortas according to the manufacturer‟s instructions (Invitrogen, 
Carlsbad, CA, USA). A human bone marrow derived mesenchymal stromal 
cells cell, taken  from the repository at the Department of Histology, 
Embryology and Applied Biology, University of Bologna, were  used as a 
positive control. In brief, the cells were homogenized with Trizol reagent, 
collected in a eppendorf tubes and then incubate for 5 min at RT. To 
generate  the phase separation, an ad hoc quantity of chloroform was added 
(0.2 ml for 1 ml of Trizol); the samples were then shacked vigorously for 15 
seconds and incubated for 2 to 3 min. at RT. The samples were then 
centrifuged at 12000g for 15 min at 4°C. After this step, the RNA remains 
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exclusively in the aqueous phase. After collected the aqueous phase in a 
new tube, the RNA was precipitated by adding isopropyl alcohol (0.5 ml of 
isopropyl alcohol for 1 ml of initial Trizol reagent). The samples were then 
incubated at RT for 10 min, centrifuged at 12 000 g for 10 min at 4°C to 
allowed RNA to precipitate. After removed the surnatant, the gel like pellet 
RNA was suspended in 75% alcohol for washing (1 ml of 75% alcohol for 
1 ml of Trizol), centrifuged at 7500 g for 5 min at 4°C , air-dried, dissolved 
in Rnase free water (DEPC water) and quantified. The evaluation of the 
quality was assessed measuring the A260/A280 ratio. Reverse transcription 
reactions were performed using 2μg of total RNA following the 
manufacturer‟s protocol (Invitrogen, Carlsbad, California). The cDNA was 
stored at –20 °C until PCR reactions were performed. PCR were carried out 
as follows: 1μl of cDNA was amplified using specific primers in PCR 
reaction mix (reaction buffer 10x, MgCl2 2mM, dNTP 0.2mM, primers 0.2 
mM and 1.25 U of Taq DNA polymerase). PCR program was:  
- denaturation 94°C for 2 min 
- denaturation 94°C for 1 min  
- annealing: specific for each primer used for 1 min 
- extension 72 °C for 1 min 
- final extension 72°C for 7 min 
Each cycle was repeated for 29 times. Specific primers sequences 
(Forwards and Reverse), annealing temperatures and amplicon length are 
reported in the table below (Table 1). PCR products were visualized on a 
1.8% agarose gel stained by ethidium bromide.(Pasquinelli et al., 2007 b). 
 
 
 
Experimental Design-Materials and Methods 
58 
 
 
Table. 1: Forward and reverse primers, annealing temperature and amplicon 
length for each gene are reported. 
 
 5.18 ENDOTHELIAL DIFFERENTIATION OF ADULT STEM 
CELLS FROM HUMAN THORACIC AORTAS  
To demonstrate if adult stem cells isolated from human thoracic aortas are 
able to differentiate into endothelial cells phenotype, we performed an in 
vitro angiogenesis assay according with Oswald and et. (Oswald et al., 
2004). Cells , at passage 5, were cultured until near confluence for 7 days in 
two different condition. The cells induced were plated at the density of 
25.000 cells/cm
2
 in a T25 culture flasks, and subsequently cultured for 7 
days in D-MEM plus 2% FBS and with 50 ng/ml of VEGF (Sigma, Milan, 
Italy). Control cells were plated at the density of 4.000 cells/cm
2
 in a T25 
culture flasks and cultured in D-MEM plus 10% FBS without growth factor 
(VEGF). For both the conditions, the medium was change every 2 days. 
After this period, the cells were harvested by treatment with 0.05% trypsin-
EDTA  and then used for different assays.(Pasquinelli et al., 2007 b). 
 
 
gene 
T 
annealing 
amplicon 
length forward primer reverse primer 
OCT4  60°C 169 bp 
5‟-CTT GCT GCA GAA GTG GGT GGA GGA 
A-3‟ 5‟-TGC CCG AAA CCC ACA CTG CAG-3‟ 
BMI-1 57 °C 369 bp 
5‟-GGA GAC CAG CAA GTA TTG TCC TTT 
TG-3‟ 
5‟-CAT TGC TGC TGG GCA TCG TAA G –
3‟ 
BCRP-
1 65 ° C 652 bp 
5‟-GTT TAT CCG TGG TG 
T GTC TGG-3' 5‟-CTG AGC TAT AGA GGC CTG GG-3‟ 
CD133 62 °C 337 bp 5‟-CTG GGG CTG CTG TTT ATT ATT CTG,  
5‟-GTA CAA CAC TAC CAA GGA CAA 
GGC GT-3‟ 
KDR 62 °C 555 bp 5‟ TAT AGA TGG TGT AAC CCG GA-3‟ 5‟ TTT GTC ACT GAG ACA GCT TGG-3‟ 
C-Kit 67 °C 275 bp 5‟ GTC TCC ACC ATC CAT CCA TC-3‟ 5‟CAT ACA AGG AGC GGT CAA CA-3‟ 
IL6 57 °C 388 bp 
5‟GAG AAA GGA GAC ATG TAA CAA GAG 
T-3‟ 5‟ GCG CAG AAT GAG ATG AGT TG-3‟ 
beta 
2µ 58 °C  114 bp 5‟-ACC CCC ACT GAA AAA GAT GA-3‟ 5‟-ATC TTC AAA CCT CCA TGA TG-3‟ 
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5.18.1 In Vitro Matrigel assay :  
Matrigel (BD Biosciences), according to the manufacter‟s instructions, at 
low temperature is a liquid form while at the high temperature is  like a gel 
formulation. A 96 culture plate was put in ice and then 50 µl/well of cold 
Matrigel were dispensed. The plate was then incubate at 37°C for 30 min. 
to allow the Matrigel solution to solidify. The cells of both the conditions 
after collection from the flasks, were counted and plated at the density of 
5x10
3
 in each well above described. Human umbilical vein endothelial cells 
(HUVEC) were used as a positive control. The plate was then cultured at 37 
°C / 5% CO2 and the formation of capillary like structures were observed in 
a CKX41 Olympus inverted microscope after 2, 4 , 6, and 20 hours. Each 
experiments were performed in triplicate.   
 
5.18.2 TEM  analysis:  
To visualize ultrastructural features of endothelial differentiation, the 
structures, obtained in Matrigel after 20 h, were fixed “in situ” with 
buffered 2% paraformaldehyde for 1 h at 4°C. According with the protocol 
above described for TEM analysis (see paragraph 5.5), fixation, 
postfixation, dehydration and embedding steps were performed dispensing 
the appropriate solution into each well. Once the resin polymerized, the 
blocks were removed from each well and carefully cut until the structures 
previously observed by inverted microscope were reached. The ultra-thin 
sections were counterstained and analyzed by an FEI Tecnai 12. 
 
5.18.3Flow Cytomery Assay:  
The cells from both the two conditions (induced and controls) , after the 
Trypsin‟s protocol,  were analyzed at flow cytometry using the following 
anti-human MoAbs: KDR-APC (RD Systems, Minneapolis, MN) to detect 
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surface expression of VEGF receptor 2 and vWF (DakoCytomation) to 
detect the cytoplasmic expression of vWF. For the expression of vWF, the  
cells were permeabilized with the Intrapep Kit (Beckman-Coulter) and then 
incubated with vWF MoAb for 1 h at RT. After two washes with PBS, cells 
were incubated with FITC anti mouse IgG (Beckman Coulter) for 30 min at 
RT. Samples were then washed twice over and incubated for 20 min with 
normal mouse Ig (Sigma), to saturate free anti mouse IgG sites. CD105 PE 
was added and incubated for 20 min and washed twice. Analyses and data 
collections were performed as described above (see paragraph 5.14). 
 
5.18.4 In situ Immunofluorescence assay:   
To visualize the expression of vWF, the cells, conditioned and controls , 
were seeded (5000 cells/cm2) on glass coverslips placed in 6-well plates 
and cultured. After fixation with 2% parafomaldehyde plus 0.1 % Triton X 
100 to permebilize the cells membrane , the samples were stained with a 
MoAb against vWF (1:50, DakoCytomation). For the immunofluorescence 
staining, the same protocol described above was used (see paragraph 5.15). 
The mean percentage of vWF+ cells was calculated by counting positive 
cells on digital images taken from 10 randomly selected fields at a 
magnification of 40 x. At least 100 DAPI+ cells were analyzed each 
sample. 
 
5.18.5 CD133 and  KDR mRNAs expression by RT-PCR 
A molecular assay , using the same protocol specified above (see paragraph 
5.17) was done to verify whether VEGF treatment could modify the 
expression of KDR and CD133 mRNA 
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5.18.6 Quantification of NOS mRNAs expression by Real Time PCR  
The assay for NOS isoforms mRNA expression was optimized for the Light 
Cycler version 3.5 (Roche
 
Molecular Biochemicals, Mannheim, Germany), 
with a RT-PCR in two steps. RNA extraction was performed using a High 
Pure RNA Isolation Kit and reverse transcription using Transcriptor First 
Strand cDNA
 
Synthesis Kit (all reagents from Roche Diagnostics, 
Mannheim, Germany) according
 to the manufacturer‟s instructions. eNOS 
mRNA expression was quantified relative to the β-actin housekeeping gene. 
The primer
 
sequences were as follows: β-actin, sense 5'-TTG GCA ATG 
AGC GGT TCC-3'
 
and antisense 5'-AGC ACT GTG TTG GCG TAC-3'; 
PCR fragment
 
of 148 bp. eNOS, sense 5'-GGA CAT TTT CGG ACT CAC 
ATT G-3'
 
and antisense 5'-GCT GTC GCT CCT GCA AAG A-3'; PCR 
fragment
 
of 77 bp. Real-time PCR was performed in Light Cycler 
capillaries
 
using a master mix containing TaqMan DNA
 
polymerase and  
the respective probes for each NOS type mRNA (Light Cycler TaqMan 
Maste, Roche Molecular Biochemical). DNA fragment
 
amplification was 
performed after the addition to the master mix of primers (final 
concentration: 0.5 µM) and template cDNA (10 to 100 ng). The protocol 
was the following: 1 cycle at 95 °C for 15 min for the initial enzyme 
activation, then 45 cycles of
 
denaturation (94°C for 10 s), annealing (60 to 
63°C for 10
 
s) and extension (72°C for 6 to 15 s). In order to verify the 
purity of the products, a melting curve was produced after the
 
completion of 
each PCR amplification by increasing the temperature of the reaction 
mixtures up to 95 °C, by 0.1 °C/s, starting at 60 °C for 60 s. The Roche 
software uses the second derivative maximum method to calculate the 
fractional cycle numbers where the fluorescence rises above background at 
the fastest rate (crossing point, Cp). The amount of mRNA was calculated 
according to Pfaffl (Pfaffl, 2001) relative to the housekeeping gene β-actin. 
All the values are normalised to the corresponding mRNA of NOS isoforms 
expressed by HUVECs at passages between 3 and 6
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6. RESULTS 
6.1 FRESH AND CRYOPRESERVED ARTERIAL TISSUE: 
HISTOLOGY ANALISYS 
At the beginning of this study, we want to evaluate the structural integrity 
and viability of Smooth Muscle Cells (SMC), the effectors of blood vessel 
contractile responses, in cryopreserved and unfrozen human aortas 
harvested from five multi-organ donors (mean age 40 years; 4 male and 1 
female), thanks to a collaboration with Cardiovascular Tissue Bank, 
Policlinico S.Orsola- Malpighi,  Bologna, Italy. At light microscopy 
analysis, fresh human thoracic aortas were normal except for a patchy 
distribution of luminal endothelium (Fig 19) ;after thawing, the histological 
picture was similar to that of unfrozen arteries, even if endothelial cells 
were little represented. Focal changes, including nuclear polymorphism, 
hypercromasia and nuclei collapse were seen in SMCs (Fig. 20a); small 
bar-like areas of tissue clearings were found close to SMCs (Fig. 
20b)(Pasquinelli et al., 2006). 
 
Fig.19: Light Microscopy 10X.  Fresh Human Thoracic Aorta from 
multiorgan donor. Particular of the media: no degeneration‟s signs, the 
media appeared well preserved. (Pasquinelli et al., 2006). 
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Fig. 20: Light Microscopy 20X: Human Thoracic Aortas after 
cryopreservation: LM shows a normally looking media with nuclear 
polymorphism and hypercromasia (       , a) and  with focal perinuclear 
clearings  close to SMCs (     , b) . (Pasquinelli et al., 2006). 
 
6.2 FRESH AND CRYOPRESERVED ARTERIAL TISSUE : TEM 
ANALYSIS 
The ultrastructural analysis performed on fresh human arterial tissue 
revealed minimal feature of SMC injury including vesicular nuclei and 
oedematous mitochondria. This kind of findings could be correlated with 
the time of cold ischemia existed between the explants and the arriving at 
the Cardiovascular Tissue Banking. (Fig.21). 
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Fig 21: Transmission Electron Microscopy. Fresh Human Thoracic Aortas 
from multiorgan donor. Minimal feature of SMCs damage; particularly of 
edematous mitochondria.(6000X) 
 
After cryopreservation, ultrastructural analysis showed significant 
alterations nuclei-cytoplasmatic in the SMC. The analysis revealed smooth 
muscle cell‟s nuclei with condensed chromatin and dark stained cytoplasm 
(Fig. 22 a); foci of contractile filament loss, small collections of lipid 
droplets and oedematous mitochondria were a common finding; the areas of 
tissue clearings observed at LM were located between the SMC plasma 
membrane and the innermost portion of the contractile cytoplasm; they 
appeared as empty cytoplasmic zones with granular and filamentous 
remnants (Fig. 22 b) (Pasquinelli et al., 2006). 
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Fig. 22: Transmission Electron Microscopy : Cryopreserved human arterial 
tissue:  a) a smooth muscle cell (SMC) with homogeneous chromatin 
clumping (single arrow), and dense cytoplasm. 3600X; b) 
subplasmalemmal structureless area ( double arrow) of SMC cytoplasm 
corresponding to the clearings seen at LM. 6900X.(Pasquinelli et al., 2006). 
 
This results confirmed that cryopreservation induce several damage at the 
vessel‟s wall, in particular in the luminal endothelial cells, but also 
demonstrate that, cryopreservation procedures induced different damage to 
the SMC, the principal effectors of blood vessel contractile 
responses.(Pasquinelli et al., 2006 a). 
 
6.3 IN SITU CELL PRESERVATION : 
IMMUNOHYSTOCHEMISTRY RESULTS 
In order to evaluate the in situ cell preservation of arterial tissue before and 
after cryopreservation, we performed an immunohistochemical studies on 
paraffin sections using monoclonal antibodies to detect endothelial cell 
CD34 antigen  and smooth muscle actin (ASMA) . CD34 is a 
transmembrane protein that defined ˜ 1% of normal bone marrow 
mononuclear cells including hematopoietic precursors/stem cells and 
normal endothelial cells. ASMA is a alpha-Smooth muscle (alpha-sm) 
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actin, an isoform typical of smooth muscle cells (SMC) and present in high 
amounts in vascular SMC, where was localized in microfilament bundles. 
In this studies, CD34 immunohistochemical staining showed a reduction in 
the number of luminal endothelial cells after cryopreservation, even if a 
positive CD34 immunostaining was found in the endothelial cells lining the 
vasa vasorum adventitial. (Fig 23)   
 
Fig. 23: Human Thoracic Aortas: CD34 staining; a) unfrozen arterial 
sample; b) Cryopreserved arterial sample 
The general pattern expression of ASMA in  cryopreserved aortas was 
similar to the expression pattern seen  on unfrozen arteries, except for some 
unreactive zone in the media layer. (Fig 24) 
 
  Fig.24: Human Thoracic Aortas: ASMA staining; a) unfrozen arterial 
sample; b) Cryopreserved arterial sample. 
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6.4 IN SITU CELL DEATH: TUNEL ASSAY 
The in situ cell death detection was investigated in unfrozen and frozen 
arterial tissue using the TUNEL (Terminal deoxynucleotidyl transferase-
mediated dUTP nick-end labeling) assay, which reveals “in situ” DNA 
strand ruptures. This assay revealed directly in situ the apoptotic cells, is a 
precise, simple and fast method without the use of radioactive substances. 
Cleavage of genomic DNA during apoptosis may yield double-stranded, 
low molecular weight DNA fragments( mono-and oligonucleosomes) as 
well as single strand breaks “ nicks” in high molecular weight DNA. Those 
DNA strand breaks can be identified by labeling free 3‟-OH termini with 
modified nucleotides in a enzymatic reaction. In the “ In situ Cell Death 
Detection Kit” the DNA strand breaks were labeled with Terminal 
deoxynucleotidyl transferase( TdT), which catalyzes polymerization of 
labeled nucleotides to free 3‟-OH DNA ends in a template-independent 
manner. The  incorporated fluorescein  was detected by anti-fluorescein Fab 
fragments from sheep, conjugated with horse-radish peroxidase (POD). 
After substrate reaction, stained cells can be analyzed under a LM. 
For this experiments, we analyzed  n. 6 human thoracic aortas before the 
procedures of cryopreservation and n. 10 of human thoracic aortas after the 
cryopreservation protocol. The reactions were observed at light microscope, 
using a specific software (Image pro plus) connected to a CCD camera.  
Light microscopy analysis showed that the principal type of cells  which 
resulted positive at the staining was the smooth muscle cells, principal 
component of the arterial media layer. (Fig 25)(Pasquinelli et al., 2006). 
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Fig 25: TUNEL ASSAY, Light Microscopy 10X. a) Unfrozen arterial 
tissue; b) Cryopreserved arterial tissue : SMC resulted positive staining 
(brown nuclei) (Pasquinelli et al., 2006). 
 
In order to perform a semi quantitative analysis of the positive cells, we 
took series pictures of the total area for each samples and subsequently the 
imagines were evaluated by Image Pro Plus software. The results, after 
counting the number of positive cells, revealed that percentage of TUNEL 
stained SMCs ranged from 0.3 to 6.2% (average of 4.2% labeled SMCs) in 
unfrozen human thoracic aortas, while after cryopreservation the percentage 
increased from 2.8 to 16.5% with an average of 8.6% (Fig. 26)(Pasquinelli 
et al., 2006). 
           
Fig. 26: Average of TUNEL positive cells in unfrozen and frozen human 
arterial tissue. 
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This results confirmed that cryopreservation procedures induce loss and 
death of SMCs.(Pasquinelli et al., 2006).  
 
6.5 ISOLATION CELLS FROM CRYOPRESERVED 
ALLOGRAFTS: FLOW CITOMETRY STUDY 
We tried to isolate cells from cryopreserved human allografts using an 
enzymatic and mechanically methodology/approach, in order to assess in 
vivo cell viability. On the primary isolated obtained, we performed a flow 
citometry 7-ADD staining, a nuclear dye that is excluded by viable cells but 
penetrate cell membranes of dying or dead cell and it is generally used to 
identify necrotic and late apoptotic cells,  and also we used flow cytometry 
to establish the phenotype of cells isolated from cryopreserved allografts 
(CD34 and ASMA staining). Flow cytometry 7-AAD staining of 
cryopreserved homograft isolates documented that an average of 49 ±16% 
cells were unlabeled thus suggesting that a reduced cell fraction was still 
alive at the time of analysis. As shown in Table 2, in three cases the 
percentage of unlabeled cells was less than 50%, while two samples showed 
more satisfactory results, i.e., 56 and 75%.  Flow cytometry 
immunophenotyping showed that SMCs were the major cell component 
present in the primary isolates (an average of 76 ±12% cells were ASMA 
positive); the CD34 positive endothelial cells were a minor fraction only 
(percentages of CD34+ positive cells ranged from 3.9 to 0.01%). (Table 2). 
Since ASMA staining requires cell permeabilization, we were not able to 
determine the absolute 7-AAD unstained fraction of ASMA-positive cells. 
This date demonstrate that the cryopreservation procedures induced an 
important loss of viability for all type of cells, e.g. ECs and SMCs 
(Pasquinelli et al., 2006). 
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Table 2:  The table schematizes the mean percentages of 7-AAD unlabeled 
(line 1), ASMA positive (line 2), and CD34 positive (line 3) cells found in 
primary isolates recovered from cryopreserved human thoracic aortas (n. 5 
samples harvested from heart beating donors, first letters of each individual 
donor‟ name [i.e., ZI, LU etc.] are indicated. Flow cytometry assay. 10,000 
events per analyses. The percentage is a mean of a triplicate examination 
/each donor. 7-AAD dye unlabeles structurally viable cells; ASMA 
monoclonal antibody stains smooth muscle cells and CD34 monoclonal 
antibody stain  endothelial cells (Pasquinelli et al., 2006). 
 
6.6 ORGAN CULTURE: LM E TEM 
Since the results described before confirmed that the 
cryopreservation/thawing procedures altered the structure and the viability 
of the principal cells that reside in the arterial wall, e.g. SMC and EC, we 
want to investigate if this cells showed the ability to recover 
cryopreservation/ thawing damage in a in vitro organ cultures. Little 
fragment of fresh and cryopreserved human allograft were cultured in a 
RPMI 1640 with L-Glutamine, 10% FCS and 1% Penicillin/Streptomycin 
in a 37 °C incubator with 5% CO2.  After culturing for 4, 8, and 15 days 
tissues were processed for LM and TEM analysis. LM did not reveal 
significant differences between unfrozen and cryopreserved samples in 
organ cultures taken at 4 days and 15 days (Fig. 27 a-b) .TEM analysis 
DONORS Z.I. L.U. D.B. R.U. N.U. 
VIABLE 
CELLS 56% 37% 75% 37% 43% 
ASMA+ 66% 68% 93% 84% 71% 
CD34+ 3.9% 2.28% 0.01% 1.5% 2.1% 
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showed at 15 days of culture, some signs of SMC‟s degeneration like the 
presence of chromatin clumping. (Fig.27 c)(Pasquinelli et al.,2006). 
 
 
Fig. 27: Organ culture of an unfrozen Human Thoracic Aortas. At LM no 
significant decrease in the number of SMCs is seen during culture 
conditions (a, 4 days; b, 15 days); after 15 days SMCs shows peripheral 
chromatin clumping (arrow) (c, TEM, 3600X) )(Pasquinelli et al., 2006). 
However, a progressive reduction in the number of SMCs from day 4 to day 
15 associated with degenerative ultrastructural changes were found in 
cryopreserved samples when compared to controls (Figs. 28 and 29) 
(Pasquinelli et al., 2006). 
 
Fig.28: Organ culture 4 days of a cryopreserved HTA. a) reduction in the 
number of SMCs during culture conditions is seen by LM (10X) ; b) TEM 
shows progressive loss of SMC structural integrity (3600X)(Pasquinelli et 
al., 2006). 
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Fig. 29: Organ culture 15 days of a cryopreserved HTA. a) loss of SMC in 
the media layer is seen by LM (10X); b) TEM snows ultrastructural 
degeneration of SMC (3600X)(Pasquinelli et al., 2006). 
However, even if this results demonstrated that the damage of parietal SMC 
could only partially recovered by organ colture “ in vitro”, in this 
experiments we were able to see, by LM and TEM, just at day 4, that the 
zone between media and adventitial layer, which represents the zone of 
nutritionals changes, was well preserved with some vasa vasorum vital (Fig. 
30). 
  
Fig. 30: Organ culture 4 days of a cryopreserved HTA. a) LM showed the 
presence of well preserved vasa vosorum located in the adventitial layer. b) 
Ultrastrctural features of adventitial vasa vasorum vital by TEM.  
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6.7 ANTIGENICITY PRESERVATION: 
IMMUNOHISTOCHEMICAL STAINING FOR HC-10 E NAMB-1: 
Subsequently, we tried to establish whether the cryopreservation procedure 
can modify arterial homograft antigenicity. So we performed an 
immunohistochemical study on fresh and cryopreserved human arterial 
homografts in order to visualize the expression of HLA class I heavy and 
light chains „„in situ‟‟ by using the HC-10 and Namb-1 monoclonal 
antibodies. To standardize immunostaining, flow-cytometry indirect 
immunofluorescence analysis was performed on HUVEC (Fig.31 a-d); 
immunohistochemistry of human ovarian cortical vessels was performed as 
an additional positive control, where endothelial cells  showed an intensity 
of HC-10 (Fig. 31) and Namb-1 (Fig.31f ) immunostaining which was 
comparable to that previously seen in ovarian  and submandibolar gland  
tissues. Negative controls were performed by omitting tissue incubation 
with primary antibodies. The HC-10 antibody recognizes an epitope 
expressed on virtually all b2-microglobulin- free HLA-B heavy chains and 
on b2-microglobulin- free HLA-A10, HLA-A28, HLA-A29, HLA-A30, 
HLA-A31, HLA-A32 and HLA-A33 heavy chains. The Namb-1 antibody 
recognizes both free and HLA class I heavy chain-associated human b2-
microglobulin (Pasquinelli et al., 2007 a). 
 
Fig 31: a-d) Representative examples of flow-cytometry of unfixed 
HUVEC : (a) negative control; (b) HC10 MoAb; (c) W6/32 MoAb; (d) 
Namb-1 MoAb. e–f) Immunohistochemistry analyses performed on human 
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ovarian cortical vessels, used to standardize immunostaining with HC-10 
and Namb-1 MoAbs. (e) HC-10 MoAb; (f) Namb-1 MoAb. Original 
magnification (e, f) 250X.(Pasquinelli et al., 2007 a). 
 
The immunohystochemical results  obtained on fresh human arterial tissue 
showed that, in the intima, HLA class I antigens were markedly expressed 
by luminal endothelial cells; the positivity was intense and found both on 
cell membrane and in the cytoplasm; in the media smooth muscle cells 
showed a diffuse and moderate staining with HC-10; in the adventitia we 
found a well-developed network of vasa vasorum whose endothelial cell 
lining was intensely stained with a pattern similar to that of luminal 
endothelium; when compared to endothelial cells, smooth muscle cells of 
the same vessels showed a lower expression of the HLA class I antigens. 
The cell staining pattern of Namb-1 was similar to that of HC-10. 
Representative results are shown in Figs. 32 a, c, e and 33 a, c, e.  
In cryopreserved arterial allografts the expression of HLA class I antigens 
was comparable to that observed in fresh, unfrozen tissues; however, as a 
consequence of surface endothelium damage induced by cryopreservation 
we found a decreased expression of HLA class I antigens in the luminal 
intima; no difference of HLA class I and b2-microglobulin expression was 
found in the adventitia with respect to fresh arterial tissue. Representative 
results are illustrated in Figs. 32 b, d, f and 33 b, d, f. This data confirmed a 
previous study of our group,  which demonstrate that cryopreserved 
allograft, like the fresh counterpart, induced an immunological response in 
the donors (Mirelli et al., 2005), and also demonstrated that the endothelial 
cells in the adventitial vasa vasorum are the principal cells that induced an 
immunological response (Pasquinelli et al., 2007 a). 
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Fig. 32: Representative 
examples illustrating the 
HC-    10 
immunoreactivities seen in 
the different layers of fixed 
and routinely processed 
samples from fresh (a, c, e) 
and cryopreserved (b, d, f) 
human arterial allografts. 
Note that no significant 
difference of HLA I heavy 
chain antigen expression 
was found between fresh 
and cryopreserved arterial 
allografts. HC-10 
immunostaining is intense 
in endothelial cells lining 
the surface intima (a) and 
adventitial vasa vasorum (c, 
e, f), moderate and diffuse 
in medial smooth muscle 
cells (b, c, d). Original    magnification (a–f) 100x (Pasquinelli et al., 2007 a). 
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Fig. 33: Representative 
examples illustrating The 
Namb1immunoreactivitie
is seen in the different 
layers of fixed and 
routinely processed 
samples from fresh (a, c, 
e) and cryopreserved (b, 
d, f) human arterial 
allografts. Alike Fig.16 
no significant difference 
of HLA I light chain 
antigen expression was 
found between fresh and 
cryopreserved arterial 
allografts. Namb- 1 
pattern of 
immunostaining is 
comparable to that of 
HC-10. Original 
magnification (a–f) 100 
X·(Pasquinelli et al., 
2007 a). 
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6.8 IDENTIFICATION IN SITU OF A “VASCULOGENIC ZONE”: 
IMMUNOHYSTOCHEMICAL STUDIES:  
In according with the previous results that identified, in human thoracic 
aortas, a zone between the media and the adventitial layers in which are 
present cells that remain vital, proliferate in organ culture system and  
maintain the expression of HLA-class I after cryopreservation procedures,  
we performed an immunohystochemical studies to better characterize this 
cells population. Therefore, in order to identified a vasculogenic zone in 
situ where the adult stem cells could be present, the immunohystochemical 
studies, were performed on fresh human femoral arteries and thoracic aortas 
harvested from multiorgan donor, collected at the Cardiovascular tissue 
banking, S.Orsola-Maplighi Hospital, Bologna, Italy. It‟s now that arteries 
are constituted of an endothelial layer (intima), while the tunica media, the 
middle layer of the walls of arteries,  is composed of smooth muscle and 
elastic fibres. For this studies, we used different type of monoclonal 
antibodies to characterized the cell populations presents in the arterial wall, 
like: 
- CD34: a transmembrane protein that defined ˜ 1% of normal bone 
marrow mononuclear cells including hematopoietic precursors/stem 
cells and normal endothelial cells 
- vWF: Factor VIII related antigen is more appropriately know as the 
von Willebrand factor; it is a glycoprotein and is complexes with 
factor VIII related antigen in plasma. Factor VIII is also present in the 
endothelial cells where is shows a granular pattern of reactivity.  
- CD45: recognizes a family of proteins known as the leukocyte 
common antigen exclusively expressed on the surface of almost all 
haematolymphoid cells and their progenitors 
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- S-100: normally present in cells derived from the neural crest 
(Schwann cells, melanocytes, and glial cells), chondrocytes, 
adipocytes, myoepithelial cells, macrophages, Langerhans cells, 
dendritic cells, and keratinocytes. S100 proteins have been implicated 
in a variety of intracellular and extracellular functions, are involved 
in regulation of protein phosphorylation, transcription factors, Ca++ 
homeostasis, the dynamics of cytoskeleton constituents, enzyme 
activities, cell growth and differentiation, and the inflammatory 
response. 
- CD68: higly glycosylated lysosomal glycoprotein present in the 
cytoplasmatic granules of monocytes, macrophages, neutrophils, 
basophils and large lymphocytes; it also can be expressed in the 
cytoplasm of non-hematopoietic tissue 
- C-Kit: C-kit is a proto-oncogene, which encodes for growth factor 
receptor protein KIT (Cd117), the receptor for stem cell factor. It is 
expressed in hematopoietic stem cells, tissue mast cells, basal cells 
line of the skin, epithelial cells of the breast, melanocytes, germ 
cells..  
- Ki-67: a marker of cell proliferation which recognizes a nuclear 
protein expressed in the G1, S, M, and G2 phases of the cell cycle. 
 
The immunohystochemical results showed a distinct CD34+ and Ckit+ 
cell population between the media and adventitia 
layers.(Fig.34)(Paquinelli et al., 2007 b). 
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Fig.34: “ Vasculogenic zone” at the border between adventitia e media 
layers. a) CD34 positive cells; b) C-kit positive cells 
 
Unlike femoral arteries which show a thin layer of CD34+ capillary-like 
structures at the border between the media and adventitia (Fig.35A), in 
the human thoracic aortas , we observed a more complex network of 
CD34+ cells which also extended into the adjacent media and adventitia 
layers.  The CD34+ cells were arranged both as single elements and 
capillary structures with evident lumina. (Fig. 35 B). The  
immunostaining for vWF (a mature endothelial markers) only stained 
some of the larger vascular channels present in the adventitia layer. 
Besides, CD34+ vascular channels were also seen in the media, which 
adjacent tissue sections showed to be vWF- (Fig.35 C-D)(Pasquinelli et 
al., 2007 b). 
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Fig. 35 : IHC results for CD34 and vWF staining A) Femoral artery, B-
D) Thoracic aorta, Scale Bars are 50 μm. 
 
CD45+ were seen in association with the CD34+ cell network and it 
could be connected with a  inflammatory cells near the vasa vasorum 
adventitial. Further, rare CD68+ and S-100 + elements cells were found 
were found in the adventitial layers connected with vasa vosorum 
(Fig.36) 
 
 
 
Fig.36: Immunohystochemicals reactions performed on fresh human 
thoracic aortas for CD45, CD68, S-100. Rare positive elements were 
found in the advential layers a) CD45 staining; b) CD68 staining; c) S-
100 staining 
 
The second population of round stromal cells, C-Kit + were observed in 
the adventitia close to the richly vascularized border. Only in the thoracic 
aortas, we found rare C-kit + elements in the subintimal layers, 
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adventitial vasa vasorum and some stromal elements.  This cells were 
present in cluster, above all in couple. This cells are CD34, CD68, S100 
negative; some were CD45+ (Fig. 37 A-D). 
 
 
 
Fig. 37: Immunohystochemical analysis for Ckit performed on human 
thoracic aortas. A) positivity cells in the sub-intimal layer B) positivity 
cells in the adventitia layers; C) perivascular ckit+ cells; D) Stromal 
Ckit+ cells 
This type of cells, C-kit, which is commonly associated with the more 
primordial cardiac stem cells  is also expressed by mastzellen; however, 
at the histology analysis the CKIT+ cells showed eosinophil cytoplasm, 
elevated ratio nucleo/cytoplasm and eccentric nucleo; ultrastructural 
examination of the same samples ruled out this possibility, 
demonstrating that this cells are indifferentiated cells (results not shown).  
Stem cells are quiescent cell that, under internal and external signals, 
undergo to a asymmetrical divisions. Ki-67 is a marker of cell 
proliferation and is able to recognize a nuclear protein expressed in the 
all phase of the cell cycle, except the G0 phase. The 
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immunohistochemical assay for Ki67 exclusively stained individual 
endothelial cells and stromal cells located between the media and 
adventitia. (Fig 38-39). This data indicated that cells with high growth 
potential are located in a restricted area of the aortic wall corresponding 
to the site of CD34+ and ckit + cell residence. (Fig.34)(Pasquinelli et al., 
2007 b). 
 
Fig.38: Ki67 immunostaining. a) endothelial cells and stromal cells in 
the zone between the media and the adventitia.; b)adventitial vasa vorum 
with Ki67 + cells. 
 
 
Fig.39.  Particular of Ki67+ cells integrated in a little vessel. 
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6.9 ISOLATION AND ESPANSION OF ADULT STEM CELLS 
FROM FRESH HUMAN THORACIC AORTAS 
Taken together the  previous data  presupposed  the presence of resident 
adult stem cells within the human arterial wall. The successive step was 
tried to isolation this kind of cells from fresh human thoracic aortas. Like 
described in materials and methods section, we isolated the cells from a 25 
cm2 of tissue, using a combination of enzymatic and mechanical 
procedures. Cell isolation was carried out successfully in 3 of the 10 cases. 
In the remaining 7 cases cell cultures were discarded due of a fast growth of 
contaminant bacteria and fungi. This type of contamination didn‟t derived 
from biological contamination of media, solution or incubator but, the  
microbiological assays performed on the solution used for delivering 
arterial grafts to the Cardiovascular Tissue Bank facility  revealed the 
presence of the bacterial species and yeasts listed in Table n.3. 
                         
Table n.3: Contaminant microorganisms responsible for unsuccessful 
cell isolation and culture (7 out of 10 cases). 
 
Started from 25-30 cm
2
 of human thoracic aortas, after the procedures of 
isolation, the total number of mononuclear cells obtained, counted with 
Methyl Violet in a Neubauer-counting chamber, varied from 1,5 x 10
6
 to 
3,5 x10
6
. The cell colonies began to appear approximately 3-4 days after 
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initial plating, and so, considering a 36 hours of doubling time of the 
isolated cells, the number of resident mesenchymal stromal cells  present in 
the primary isolate from a 25 cm
2
 sample of aorta can be estimated around 
0.5 ∼ 2.0 x 104 cells. At the beginning of the cell culture, the cells showed 
two distinct morphologies: one having a fibroblastoid appearance and the 
other one with a more rounded appearance (Figure 40 a). The rounded cells 
could be a contamination of endothelial cells, data confirmed also in flow 
cytometry analysis performed on primary isolated ( data non shown). After 
passaging, these rounded cells rapidly disappeared from culture and the 
elongated cells continued to proliferate, even after numerous passages 
(Figure 40 b) and their appearance was morphologically indistinguishable 
from that of MSCs isolated from the human bone marrow.  
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Fig. 40: MSCS from arterial tissue. a) two distict type of morphologies after 
3 days of culture, bar =20 µm; b) Typical phenotype of mesenchymal 
stromal cells after 3 passage in culture 
The cells were expanded in culture for up to 12-15  passage; they were 
cultured in collagen type 1 flasks in D-MEM plus 10 % FBS, like the 
culture of MSCS isolated from human bone marrow (Pasquinelli et al., 
2007 b). To ruled out a cellular transformation or a viral infection, 
virological assays for CMV and EBV as well as cytogenetic analyses 
resulted negative (results not shown). 
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6.10 IMMUNOPHENOTYPING: FLOW CYTOMETRY ANALYSIS 
Because the morphology of the cells isolated from human thoracic aortas 
was identical at the morphology of mesenchymal stem cells isolated from 
human bone marrow, we characterized our cells, in a flow cytometry assay, 
using the panel of antibody used to characterized the MSCs. Triple flow 
cytometry immunostaining of the cultured cells taken at passages 3-5 
revealed that these cells coexpressed molecules commonly found in MSCs, 
i.e., CD44, CD90, CD105. In particular 85% of the cell populations were 
CD44+/CD90+; 95% of CD44+/CD90+ also expressed CD105. 
Considering the results altogether, more than 80% of the overall cell 
population simultaneously expressed CD44, CD90 and CD105 molecules 
(Fig.41).Cells taken at 3-5 passages were analyzed for the single expression 
of CD166, a markers used to identified MSCs, the negativity for 
hematopoietic stem cells markers (CD34, CD45), endothelial marker (vWF, 
CD146) and for the expression of KDR, CD133, C-Kit. Besides we 
evaluated the expression for HLA class 1 and HLA-DR. Single labeling 
experiments also showed that at least 80% of the cultured cells were 
CD166+; KDR, CD34 and CD133 were found expressed in negligible cell 
fractions (0.1 to 5 %) whereas c-kit+ cells were not detected at all (data non 
shown). Cells were also negative for lineage markers, i.e., CD45, which is 
expressed in mature hematopoietic cells, CD146 and vWF which are 
markers of differentiated endothelium. Immunologically the cells expressed 
HLA class I antigens and were negative for HLA-DR. In summary, the 
phenotype of the isolated cells was CD44+, CD90+, CD105+, CD166+, 
KDRlow, CD133low, CD34low, c-kit -, CD45-, CD146-, vWF-, HLA 
classI + and HLA-DR -.(Fig.42) (Pasquinelli et al., 2007 b).  
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Fig. 41: At flow cytometry thoracic aorta MSCs co-express CD44, CD90 
and CD105 surface molecules. Percentages and cytograms from a 
representative experiment. 
 
Fig. 42: Immunophenotype of thoracic aortas MSCs at flow cytometry. 
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6.11 IMMUNOFLUORESCENCE ANALYSIS 
The in situ single immunofluorescent staining performed on cells cultured 
in chamber slides confirmed the results obtained at flow cytometry. The 
cells with a fibroblast-like morphology resulted positive for CD44, CD90, 
CD105, CD166, some cells with a smooth muscle phenotype resulted 
positive for the ASMA staining while rare elements with a rounded 
appearance resulted positive for CD45 labeling (Fig. 43)(Pasquinelli et al., 
2007 b). 
 
Fig. 43: Immunofluorescence characterization of MSCs cultured on slide 
chambers. Cells were stained with monoclonal antibodies directed against 
CD44 (A), CD90 (B), CD105 (C), CD166 (D), ASMA (E) and CD45 (F). 
Scale Bars are 10 μm. 
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6.12 ULTRASTRUCTURAL ANALYSIS OF CELL : TEM 
ANALYSIS 
Cells taken at 3-5 passages in culture were processed for ultrastructural 
analysis. Ultrastructural analysis showed cells with high ratio 
nucleo/cytoplasm, large euchromatic nuclei, prominent nucleoli and 
abundant cytoplasm containing numerous organelles, e.g., mitochondria and 
dilated cisternae of rough endoplasmic reticulum, a few lipid droplets, and 
peripheral cytoplasmic collections of clear vesicles, vacuoles and blisters 
(Fig. 44) (Pasquinelli et al., 2007 b).  
                                     Fig. 44: Ultrastructural analysis performed 
on MSCS isolated from human thoracic 
aortas taken at 3-5 passages. A) nuclei (N) 
with eucromatin finely disperse and 
prominent nucleoli (Nu). The cytoplasm 
contained some lipids droplets. Bar: 2 μm 
B) abundant cytoplasm containing 
numerous organelles, e.g., 
mitochondria(m) and dilated cisternae of 
rough endoplasmic reticulum (rER).; C) 
peripheral cytoplasmic collections of clear 
vesicles, vacuoles and blisters (bar=1 μm.) 
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All of this ultrastructural features, especially the multivacuolar 
appearance,   were described in a previous study of our group , where we 
compared the ultrastructural characteristic of mesenchymal stem cells 
derived  from human bone barrow and term placenta (amnios and 
chorion membrane)(Pasquinelli et al., 2007 c). 
In this study, electron microscopy analysis performed on BM-hMSCS 
showed cells with surface filopodia and prominent blebs; the cytoplasm 
contained intermediate filaments, contractile filaments, prominent rough 
endoplasmic reticulum cisternae, lipids and glycogen. The most 
distinctive finding observed was the presence of wide collections of clear 
vacuoles, channels, and vesicles giving the periphery of the cytoplasm a 
labyrinthine appearance (Fig. 45) (Pasquinelli et al., 2007 c). 
 
 
 
Fig. 45: TEM analysis of BM-hMSCs. Distinctive features were the 
presence of dilated cisternae of rER (A), clear blisters and vacuole 
located at the periphery of the cell cytoplasm (B); and bands of 
contractile filaments (arrows) with dense bodies were seen in association 
with surface blebs (arrowhead) (C).  
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Even if ultrastructural differences exist among phenotypically similar 
hMSCs derived from different human tissues that can be revelatory of 
their in vitro differentiation potential,  some identical features like dilated 
cisternae of rough endoplasmic reticulum and the presence of peripheral 
collection of multiloculated clear blisters are present. The last features 
could be invaginations of the cell membrane that reflect some kind of 
cell memory effect of the original environment in which the MSCs 
originally grew in different type of tissue. Besides, the elevating 
proliferating activity is a typical property of stem cells.   
 
6.13 STEM CELLS GENES EXPRESSION by RT- PCR 
The RT-PCR performed on MSCs isolated from human thoracic aortas 
and MSCs isolated from human bone marrow, as a positive control, 
showed that our cells constitutively expressed transcripts associated with 
stem cells. The MSCs isolated from human thoracic aortas  expressed the 
embryonic stem cell marker, Oct4. During embryonic development, Oct4 
is expressed initially in all blastomeres. Subsequently, its expression 
becomes restricted to the inner cell mass and down regulated in the 
trophectoderm and the primitive endoderm. Thus, it has been proposed 
that Oct4 is a key regulator of stem cell pluripotency and differentiation 
(Pan et al., 2002). Moreover, Human thoracic aortas MSCs expressed 
some transcripts involved in stem cell critical regulatory pathways, i.e., 
c-kit, that is involved in the proliferation and differentiation of HSC; IL-
6 and BCRP1, that maintaining the undifferentiated state of embryonic 
stem cells; BMI-1 , that regulated self-renewal of hematopoietic and 
neural stem cells and KDR, receptor type 2 of VEGF, as well as, to a 
lower extent, hematopoietic stem cell transcripts, e.g., CD133 (Figure 
46). The positive control, BM-MSCs, expressed all the molecules 
involved in stem cells conditions, like CD133, Oct-4, IL-6, BCRP-1, 
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BMI-1 while they didn‟t expressed the hematopoietic stem cells 
molecules Ckit and KDR.(Pasquinelli et al., 2007 b). 
 
 
 
 
 
 
      
 
       
 
 
 
 
Fig.46: RT-PCR analysis of mesenchymal stromal cells derived from the 
human thoracic aorta. The left lane shows transcript expression found in 
cells isolated from the thoracic aorta (TA-MSCs). The right lane indicates 
the expression intensity seen in parallel experiments performed on 
mesenchymal stromal cells derived from the human bone marrow (BM-
MSCs). The data  representative of a set of at least three experiments. β2μ 
was used as a house-keeping gene. Amplicon lengths: OCT4: 169 bp, BMI-
1: 369 bp; BCRP-1:  652bp; CD133: 337 bp; KDR: 555 bp; C-kit: 275 bp; 
IL6 : 388 bp; Beta 2: 114 bp;  
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6.14 ENDOTHELIAL DIFFERENTIATION OF ADULT STEM 
CELLS FROM    HUMAN THORACIC AORTAS  
Thoracic aorta mesenchymal stromal cells isolated from 3 multiorgan 
donors, according with Oswal et al.,  showed the capacity of differentiating 
in vitro into endothelial cells when cultured confluent in the presence of 2% 
FBS and 50 ng/ml VEGF for 7 days. This results was obtained using 
different technique able to demonstrate this differentiation 
potential.(Pasquinelli et al., 2007 b).  
 
6.14.1 In Vitro Matrigel assay:  
After 7 days of induction with VEGF, the cells were seeded on Matrigel, a 
matrix solution, in order to visualize the formation of capillary like 
structures. After 2 and 4 hours of Matrigel incubation, no morphological 
changes were seen in the 2 experimental conditions investigated. After 6 
hours of incubation, the cells that had previously been conditioned with 
VEGF showed,  evident morphological changes like a more elongated 
shape and distinct, thin cytoplasmic projections sprouting from the cell 
periphery. After 20 hours, the cells appeared to be connected by thicker 
projections, thus forming an evident capillary-like network. These features 
were not observed with unstimulated cells. (Fig.47) As expected HUVEC 
spontaneously aggregated in a capillary-like network when seeded on 
Matrigel (data non shown). 
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Fig. 47: MSCs aggregated in capillary-like structures when seeded on 
Matrigel. Cells were cultured for 7 days in the absence (A) or presence (B-
D) of VEGF. B corresponds to 6 hours from Matrigel seeding; C, D to 20 
hours from Matrigel seeding (Pasquinelli et al., 2007 b). 
 
6.14.2 TEM  analysis: 
The capillary like structure obtained in the Matrigel assay after 20 h of 
incubation was fixed and observed with a transmission electron 
microscopy. The in situ ultrastructural analysis  of Matrigel matrices 
showed cell aggregates having features consistent with an early endothelial 
phenotype; these characteristics included the presence of loosely arranged 
vimentin-like intermediate filaments, collections of micropinocitotic 
vesicles and caveolae, tight junctions; around the Golgi area, moderately 
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electron-dense oval-shaped granules possibly representing immature 
Weibel-Palade bodies were also seen (Figure 48); this feature was only 
observed when cells had been treated with VEGF and not in the control 
(results not shown). 
 
 
 
Fig. 48: Ultrastructural aspects of thoracic aorta MSCs cultured in the 
presence of VEGF and then seeded on Matrigel matrices for 20 hours. a) 
The cells show oval-shaped electron dense granules in the Golgi area close 
to the nucleus (black arrowhead); these granules possibly represent 
immature Weibel-Palade bodies. b) A cluster of micropinocytosis vescicles 
is seen close to the plasma membrane (arrow). c) A detail of the cell 
periphery shows a tight junction, vesicles, caveolae and loosely arranged 
intermediate filaments (white arrowheads). a,b, c bars = 0.5 μm. 
(Pasquinelli et al., 2007 b) 
 
6.14.3 Flow Cytomery Assay: 
VEGF display differential interactions with tree related receptor tyrosine 
kinases (VEGF-R1/ Flt-1, VEGF-R2/ KDR/ Flk1, VEGFr3/ Flk-4). 
VEGFr1 and VEGF r2 are restricted largely to vascular endothelium. In 
vitro, VEGF seems to have the ability to induce endothelial cells 
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proliferation as well as migratory and sprouting activity, and to help 
endothelial cells to form tubule like structures; these effects seem to be 
mediated largely by KDR. So, in parallel assays, indirect 
immunofluorescence flow cytometry revealed that KDR expression was 
significantly increased when cells had been conditioned with VEGF for 7 
days (Figure 49 A). Moreover, single (Figure 49B) and double (Figure 49 
C) labeling experiments demonstrated that VEGF promoted the vWF 
cytoplasmic expression ( marker of mature endothelium) in more than 50% 
of the CD105+ cell population. vWF expression was exclusively observed 
after cells had been treated with VEGF. (Figure 49 is representative of three 
different experiments) (Pasquinelli et al., 2007 b). 
 
Fig. 49: VEGF promotes endothelial differentiation in MSCs. Flow 
cytometry analysis of KDR (A, single labeling staining) and vWF (B, single 
labeling staining) expression in MSCs before and after VEGF incubation; 
double labelingstaining demonstrates cytoplasmic expression of vWF in 
CD105+ cells (C) (Pasquinelli et al., 2007 b). 
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6.14.4 In situ Immunofluorescence assay:   
The expression of vWF was confirmed by immunofluorescence staining of 
cells cultured on glass coverslips. In these experiments, 12 ± 3% of cells 
revealed intense cytoplasmic staining for vWF when cultured in the 
presence of VEGF; vWF expression was associated with a rounded 
morphology of the positive cells (Figure 50 b); control HUVEC showed an 
intense vWF dot-like staining (Figures 50 a)(Pasquinelli et al., 2007 b). 
 
 
 
Fig 50: Immunofluorescence staining shows vWF expression (white arrow) 
in VEGF-treated MSCs (b); vWF dot-like staining in control HUVEC (a) 
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6.14.5 CD133 and KDR mRNAs expression by RT- PCR 
RT-PCR showed CD133 (a marker of stemness) down-regulation after 
VEGF exposure (Fig. 51), indicating an acquisition of a more differentiated 
phenotype. On the other hand, after VEGF treatment, the mRNA expression 
by RT-PCR for KDR increased as expected from the flow cytometry 
results. (Fig.51)(Pasquinelli et al., 2007 b). 
 
 
Fig. 51: RT-PCR possibly documenting CD133 down-regulation and KDR 
up-regulation as a consequence of VEGF exposure.(Pasquinelli et al., 2007 
b). 
 
6.14.6 Quantification of eNOS mRNAs expression by Real Time PCR  
Real time PCR results for mRNA-eNOS quantification in unstimulated 
cells respect the VEGF-treated cells demonstrated that MSCs from 
thoracics aorta showed a basal expression of eNOS in the undifferentiated 
cells. (Data not published).This data may due to a fraction of already 
differentiated vasculogenic progenitors in the MSCs population. Anyway, 
NO seems to be important to maintain the bone-marrow stem cells in the 
undifferentiated state (Liu et al., 2007) .After 7 days of VEGF exposure , 
the mRNA eNOS expression by Real Time PCR was significantly (p <0,05) 
expressed as showed in Fig.52. May be this results must be connected with 
the up-regulation expression of KDR (Fig.52) after VEGF exposure, in fact 
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seemed that, in endothelial cell, VEGF-A induced an upregualtion of eNOS 
through KDR (Kroll et al., 1998). 
 
 
Fig. 52: eNOS expression after the VEGF exposure of aortas MSCS by 
Real Time PCR after 7 days of differentiation (p<0,05). CTR (Control) are 
unstimulated cells. VEGF are the cells treated with VEGF (50 ng/ml). The 
amount of mRNA was calculated according to Pfaffl (2001)(Pfaffl, 2001) 
relative to the housekeeping gene β-actin. All the values are normalised to 
the corresponding mRNA of NOS isoforms expressed by HUVECs at 
passages between 3 and 6. The data were expressed as mean of 2 
experiments (n=2). 
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6.  DISCUSSION 
There is some evidence that the arterial wall is much more dynamic than 
ever before believed. Hu et al. (Hu et  al., 2004)recently found abundant 
vascular progenitor cells in the adventitia of ApoE-deficient mice; these 
progenitors contributed to experimental atherosclerosis and did not 
originate from the bone marrow. Moreover, human mature endothelial cells 
have been unexpectedly found to contain a subpopulation of hierarchically 
organized EPCs (Ingram et al., 2005a). Thus, apart from the unquestionable 
link with the hematopoietic system, some progenitors seem to be located 
within the adult vessel wall. Consistent with this view, constitutively 
resident vascular progenitor cells have been isolated from the thoracic and 
abdominal aortas of healthy adult mice (Sainz et al., 2006) and from the 
internal thoracic arteries of humans (Zengin et al., 2006). Recent studies 
have indicated that the human arterial wall contains a distinct subtype of 
resident progenitor cells with vasculogenic properties (Zengin et al., 2006). 
These cells, termed vascular wall-resident progenitor cells, extend the 
spectrum of the known endothelial progenitors, which until now included 
the bone-marrow resident EPCs (CD133+, CD34+, and KDR+) and their 
circulating counterpart EPCs (CD34+, KDR+).EPCs are promising 
candidate for clinical applications aimed to restore blood supply in ischemic 
damaged tissues (Asahara et al., 1999 a). However, the number and 
function of progenitors significantly decrease with age (Riha et al., 
2005,Sethe et al., 2006) and disease (Hristov et al., 2003,Fadini et 
al.,2006). Circulating EPCs are extremely low in number (Hristov et al., 
2003). Recent studies have indicated that EPCs may play a minimal role in 
neovascularization of tumors, vessel repair or normal vessel growth and 
development (Zentilin et al., 2006,Ingram et al., 2005 b, Gothert et al., 
2004, Stadtfeld et al., 2005). Moreover, Zenging et al. hypothesized the 
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presence of a  vasculogenic zone  within the arterial wall that apparently 
contains different cell populations, like mesenchymal stem cells (Zengin et 
al., 2006). All these evidences justify the search for adequate alternative 
sources of these cells for autologous and allogenic use.  
The present work started in 2005 in collaboration with Emilia Romagna 
Cardiovascular Tissue Bank, S.Orsola-Malpighi Hospital, which 
cryopreserved vascular homografts harvested from brain-dead multiorgan 
donors (aged 15-55). We focused our attention on thoracic aortas from 
heart-beating, healthy and young multiorgan donor as new possible source 
for adult stem cells. The possibility to isolate adult stem cells from human 
thoracic aortas was realized thanks to the first results obtained from our 
group. In 2006, we demonstrated, that the cryopreservation procedures of 
arterial homografts used for clinical application damaged aortic SMC. Even 
so, the immunohystochemistry analysis, performed on fresh and frozen 
human thoracic aortas, revealed the presence of a vasculogenic zone, 
located between the media and the adventitial layer, in which a well 
preserved plexus of CD34 positive cells, lining the endhotelium of 
adventitial vasa vasorum, was found (Pasquinelli et al., 2006) . Moreover 
the organ cultures revealed the presence of vital adventitial vasa vasorum in 
the cryopreserved tissue since 4 days even so this approach was unable to 
recover in vitro the SMC‟s damage after cryopreservation. The 
ultrastructural analysis showed the presence of well preserved vasa 
vosorum located in the adventitial layer. This result seemed to demonstrate 
the existence of resident vascular progenitor cells able to resist  at the 
cryopreservation protocol and able to induce angiogenesis in ex vivo 
culture experiments. Subsequently, in another study we demonstrated that 
cryopreserved arterial allografts are immunogenic as their fresh 
counterparts. To this purpose, we performed an immunohystochemical 
study on fresh and cryopreserved human arterial tissue to visualize the 
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expression of HLA-class I heavy and light chains using “ in situ”  the HC-
10 and Numb-1 Monoclonal antibodies. HC-10 recognizes an epitope 
expressed on virtually all β2-microglobulin-free HLA-B heavy chains and 
on selected β2-microglobulin-free HLA-A heavy chains whereas Namb-1 
recognizes human free- and heavy chain associated-beta 2-microglobulin. 
This study demonstrated that  the in situ expression of HLA-I antigens is 
not altered by cryopreservation, in particular, the fact that both epitopes 
were found expressed in cryopreserved arteries could lead to the hypothesis 
that HLA class I molecules might be present in their native conformation 
(Pasquinelli et al., 2007 a). This data confirmed the previous serological 
results described in clinical studies. Immunological follow-ups of patients 
treated with cryopreserved arterial allografts unequivocally demonstrated 
that both humoral and cellular specific responses are raised in the recipients 
against donor cells within 30–60 days from surgery (Mirelli et al. 2005). 
Besides surface endothelium, smooth muscle cells and vasa vasorum 
stained positive with HC-10 and Namb-1 MoAbs. An impressive finding 
was the high numbers of vasa vasorum found in our samples. Arterial 
allografts are prepared by removing adventitia from media; however this 
surgical procedure is not sufficiently adequate to remove the vasa vasorum 
which are intimately connected to the medial layer. In our arterial samples 
vasa vasorum were found between media and adventitia and in the 
outermost portion of the media; these vessels were lined with continuous 
endothelium highly expressing HLA class I antigens  Taken together these 
results demonstrated that the vasa vasorum network, lined with highly HC-
10 positive endothelial cells, is expected to be one of the major targets of 
the „„in vivo‟‟ immunological response(Pasquinelli et al., 2007 a). As 
demonstrated by these results, a vasculogenic zone with hard-wearing  and 
immunological cells seemed to be present in the postnatal aorta tissue. The 
successive step was to performed tissue studies, using different antibodies,  
on fresh human thoracic aortas in order to identify the cell populations 
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present in the arterial tissue. Our tissue studies showed that two distinct cell 
populations, one composed of CD34+ cells and the other of c-kit+ cells, are 
present in human thoracic aortas. It is worth noting that both surface 
markers are expressed in cells with stem cell capabilities. 
Immunohistochemical tissue studies showed a well developed plexus of 
CD34+ small vessels at the border between the media and adventia layers; 
some of the cells lining these vessels were also vWF+, thus showing they 
had been employed in mature endothelium; this area, also containing 
CD45+ inflammatory cells, topographically corresponds to the CD34+ / 
CD31- cell layer, recently observed in human inner thoracic arteries and 
demonstrated to be highly vasculogenic through ring assay studies (Zengin 
et al., 2006). Rare S100 and CD68 elements were found in the same zone, 
near adventitial vasa vasorum. In addition to the vasculogenic area, CD34+ 
cells were also seen as elongated elements in adjacent portions of the media 
and adventia. CD34+ vascular channels, which adjacent sections showed to 
be vWF- , could also be found embedded within the media(Pasquinelli et 
al., 2007 b). A similar vascular organization, composed of cells highly 
expressing Human Leukocyte Antigen class I antigen (Pasquinelli et al., 
2007 a), was also before discussed and may therefore suggested that 
distinct patterns of CD34+ cell aggregation existed in elastic and muscular 
arteries. The fact that such CD34+ cells can be organized into evident 
vascular structures did not conflict with the possibility that they might be 
progenitors; in fact vascular wall-resident EPCs are believed to be the most 
likely recruitable cells contributing to new vessel formation (Ingram et al., 
2005 b). This view is in accordance with the concept of angiogenesis is 
defined as the sprouting of new blood vessels from the differentiated 
endothelium of pre-existing vessels (Carmeliet, 2000). A novel finding was 
the observation of cells expressing the stem cell surface marker c-kit which 
is commonly associated with the more primordial cardiac stem cells 
(Anversa et al., 2006).This cell subpopulation was found to be scattered 
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round c-Kit + cells, and even if c-Kit is associated also with mast cells, 
ultrastructural examinations of the contiguous  samples ruled out this 
possibility. Tissue immunostaining for Ki-67, cell proliferation marker,  
documented that cells with high growth potential are located in a restricted 
area of the aortic wall corresponding to the site of CD34+ and ckit + cell. 
Extensive observations showed that Ki67 exclusively stained individual 
endothelial cells and stromal cells located in the vasculogenic zone, while 
other cells composing the arterial wall proved negative. It remains to be 
ascertained whether these cells could have angiogenic potential and whether 
they could be perivascular pericytes (Howson et al., 2005) or an equivalent 
of the mouse and chicken mesoangioblast (Cossu et al., 2003). 
According  to these results, we tried to isolated adult stem cells from the 
thoracic aortas of multiorgan donors using a combined procedure: 
mechanical and enzymatic digestion with Collagenase type II. Under sterile 
conditions, we scraped the aorta wall until reaching the adventitial layers, 
where adult stem cells seems to be located. After enzymatic digestion, the 
minced tissue was filtered and the cells obtained, after counting with 
Methyl Violet, were seeded in culture cell plate with D-MEM 10% FBS and 
then cultured at 37°C  5% CO2.. After removing the non adherent cells , the 
attached cells shared many properties with Mesenchymal stromal cells like: 
plastic adherence; fibroblast-like morphology; high proliferation rate in 
vitro (Dominici et al., 2006). We are able to achieved adult stem cells only 
from 3 out of 10 specimens. The reasons of this unsuccessful case were 
caused by fast growth of bacteria and fungi at initial plating, due to the 
solution used for arterial graft delivery to the Cardiovascular Tissue Bank. 
Moreover, the arterial graft disinfection protocols (72 hours in an antibiotic 
mixture composed of mefoxin 240 mg/ml, lincomycin 120 mg/ml, 
colimycin 100 mg/ml, vancomycin 50 mg/ml) are not adequate for 
establishing cultures of arterial wall progenitors cells. As above reminded, 
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the cells isolated from human thoracic aortas showed a fibroblast like 
morphology, indistinguishable from that of MSCs isolated from the human 
bone marrow. Flow cytometry assay showed that more than 80% of the 
cells coexpressed molecules commonly found in MSCs such as CD44, 
CD90, and CD105. Although performed as a single staining CD166 was 
found expressed in most cells. Further, the immunophenotype profile of our 
cells was: CD44+, CD90+, CD105+, CD166+, KDRlow, CD133low, 
CD34low, c-kit -, CD45-, CD146-, vWF-, HLA classI + and HLA-DR -. 
The ultrastructural analysis showed some features that we have previously 
observed in the MSCs derived from human bone marrow, like 
multivacuolar appearance and high synthetic competence (Pasquinelli et 
al., 2007 c). Moreover, gene expression analysis by RT-PCR documented 
that Aorta-MSCs expressed gene correlate with stemness like: C-Kit, 
involved in  the proliferation and differentiation of hematopoietic stem 
cells; IL6 and BRP-1, important for maintaining the undifferentiated state 
of embryonic stem cells; BMI-1, crucial for the self renewal capacity of 
hematopoietic and neuronal stem cells. In addition, Aorta-MSCs expressed 
OCT4 transcripts that is involved in the governance of pluripotency and cell 
fate determination of embryonic stem cells. Further, the expression of 
BCRP-1 has been described in our study; this protein is linked to the 
specific ability of stem cells to exclude dyes such as rhodamine and 
Hoechst. This property identifies a small subset of stem cells termed the 
“side population” (SP) .Therefore the existence of MSCs in adult arteries is 
supported by a recent paper documenting the isolation of an SP of stem 
cells from adult aortas in healthy mice (Sainz et al., 2006). Interestingly, 
these cells were able to differentiate into endothelial and smooth muscle 
cells but failed to give rise to hematopoietic lineages. Moreover, 
considering their capacity to form vascular-like structures in vitro, these 
cells could play a major role in vasculogenisis and collateral growth. The 
presence of adult vascular wall resident MSCs has been postulated in 
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humans too (Zengin et al., 2006). The authors proposed a hypothetical 
scheme of the so-called “vasculogenic zone” sketching a complete 
hierarchy of resident stem cells niched in the arterial wall . Within that 
proposed network of progenitors we believe that the cells we have isolated 
could correspond to MSCs of the “vasculogenic zone”. At present, we do 
not know whether the MSCs we have isolated are multipotent; this aspect of 
their biology is under investigation; however, it should be noted that 
“ectopic” tissues, e.g., cartilage, bone, and fat can be seen especially in 
atherosclerotic arteries during routine histopathological observations 
(Abedin et al., 2004) and MSCs isolated from the human saphena vein are 
able to differentiate in vitro into osteoblasts, chondrocytes and adipocytes 
(Covas et al., 2005). Moreover, calcifying vascular cells isolated from the 
bovine aortic media display multilineage potential in vitro (Tintut et al., 
2003). Recently, it has been reported that human vascular adventitial 
fibroblasts from pulmonary arteries contain a cell population that has strong 
ability to differentiate into mesenchymal lineages, even so is not clear if this 
cells contains multipotent stem cells or is a mixture of committed 
progenitors cells with restricted single-potential(Hoshino et al., 2008). If 
the multi-lineage differentiation capacity of our cells is documented, the 
arteries from multi-organ donors may serve as an important source of 
multipotent MSCs for clinical needs and tissue engineering. (Pasquinelli et 
al., 2007 b). 
In according with Oswald et al, we tested in vitro if cultivating confluent 
aorta MSCs in the presence of  low-serum culture supplemented with 
VEGF-A ( 50 ng/ml) for 7 days, they were able to differentiate in vitro into 
endothelial cells like BM-MSCs (Oswald et al., 2004).VEGF-A provided 
the first example of a growth factor specific for the vascular endothelium . 
The VEGF- A through the interaction with its receptors (VEGF-R1/Flt-1, 
VEGF-R2/KDR/Flk-1) have the ability to induce cell proliferation as well 
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as migratory and sprouting activity, and to promote capillary like structure 
formation. These effects seems to maintained largely by VEGF-R2 or KDR. 
To assay in vitro angiogenesis, the cells, after 7 days of induction, were 
seeded in a three dimensional Matrigel semisolid matrix . After 20 hrs of 
culture, the MSCs were able to form capillary like structures but this ability 
was strictly depended on VEGF induction; controls always proved negative. 
Electron microscopy performed on this samples showed features consistent 
with a basic endothelial cell employment, i.e., collections of 
micropinocytotic vesicles and caveolae, tight junctions, and immature 
Weibel-Palade bodies. VEGF induction was accompanied by increased cell 
expression of KDR, as documented by flow cytometry; more importantly, 
we found that more than 50% of CD105+ cells co-expressed vWF 
following VEGF induction as indicated by double labeling experiments 
performed at flow cytometry. At immunofluorescence, vWF intensely 
stained the cytoplasm of cells with a rounded morphology (12 ± 3). 
Moreover, RT-PCR showed an increased mRNA expression of KDR after 
stimulation with VEGF, while the CD133, stemness marker, decreased after 
induction indicating an acquisition of a more differentiated phenotype. 
CD133 was first isolated from hematopoietic stem cells .CD133 or 
Prominin-1 is expressed on different types of stem cells, but it is not known 
if it plays a significant role in key stem cell functional features like self-
renewal and differentiation.  Although the biological function of Prominin-
1 is not well understood, the AC133 epitope currently serves as a useful 
marker for the isolation of hematopoietic and endothelial progenitor cells 
(Shmelkov et al., 2005), and recently Mesenchymal Stem Cells Derived 
from CD133-Positive Cells in Mobilized Peripheral Blood and Cord Blood 
showed Proliferation, Oct4 Expression, and multilineage differentiation like 
BM-MSC (Tondreau et al., 2005). Besides, CD133 seems to be a marker 
associated with more primitive stem cell phenotype than CD34 
(Handgretinger  et al., 2003). By real time PCR we evaluated the 
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expression of eNOS before and after VEGF exposure. Nitric Oxide (NO) is 
a potent vasodilatator and it is synthesized through the enzymatic 
conversion of L-Arginine and molecular oxygen to L-citrulline by nitric 
oxide synthases (NOS). There are 3 type of NOS: nNOS or neuronal NOS 
(nNOS), inducible NOS (iNOS) and endothelial NOS (eNOS). The eNOS is 
the membrane-bound isoform first found in vascular endothelial cells 
(VEC), which play a critical role in the functioning of endothelial cells. 
eNOS is essential in the signaling for vascular endothelial growth factor 
(VEGF), which is required for the development and function of endothelial 
cells (Liu et al., 2007).Moreover, eNOS is critically important in 
remodeling, hemostasis, angiogenesis, and mobilization of endothelial 
progenitors cells (Fish et al., 2006). VEGF is a key regulator factor in blood 
vessels development, endothelial biology and vascular disease, and now day 
the relationship between VEGF and eNOS/NO becomes increasingly 
defined. The quantification of eNOS mRNA by real time PCR revealed that 
, even if our cells expressed high level of eNOS in the basal situation, after 
VEGF stimulation, eNOS increased the expression. This data may due to a 
fraction of already differentiated vasculogenic progenitors in the MSCs 
population. Anyway, NO seems to be important to maintain the bone-
marrow stem cells in the undifferentiated state (Liu et al., 2007) . Recently, 
Krumenacker et al demonstated that nNOS and eNOS were present in the 
undifferentiated mouse embryonic stem cells and when ESCc were induced 
to differentiate, nNOS expression quickly decreases within 1 day, whereas 
eNOS expression increase significantly after 5 days (Hefler et al., 2001). 
Finally in our results, the cells, after VEGF exposure for 7 days, showed an 
increased eNOS expression by real time PCR. Maybe, these results must be 
connected with the up-regulation expression of KDR after VEGF treatment, 
in fact seemed that, in endothelial cell, VEGF-A induced an upregualtion of 
eNOS through KDR (Kroll et al., 1998). 
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In conclusion, the possibility of obtaining angiogenic MSCs from the 
thoracic aortas of multi-organ donors paves the way for creation of an 
allogenic bank of vascular progenitors of aortic origin. As already 
indicated, the fundamental scarcity of EPCs in the hematopoietic system is 
their main limitation when it comes to clinical application. Ex vivo 
expansion of EPCs cultured from the peripheral blood of healthy human 
volunteers yields about 5.0 x 10
6
 cells per 100 ml of blood, while the 
amount of autologous bone marrow blood aspirated for therapeutic 
neovascularization is reported to be approximately 500 ml per person 
(Tateishi-Yuyama et al., 2002). These figures suggest that at least 30-45 x 
10
7
 EPCs are required in a clinical setting. Thus the volume of blood 
required to extract an adequate number of progenitors for transplantation 
represents a practical limitation for the use of same. Under our experimental 
conditions, it can be calculated that 0.5-2.0 x 10
4
 progenitors are originally 
present in the mononuclear That fraction obtained from a 5-cm-long 
segment of human thoracic aorta; these cells expand quickly and a week 
after initial plating their expansion yields about 0.5 to 1 x 10
6
 cells. 
Considering the rate of expansion from the initial number of cells yielded, 
ideally the number of cells that could be obtained from a few in vitro 
passages might be about 1 x 10
8 
cells, a reasonable amount for a clinical 
therapeutic approach to angiogenic disorders. 
In summary, our findings indicate that thoracic aortas from heart-beating, 
multi-organ donors are highly suitable for obtaining MSCs with the ability 
to differentiate in vitro into endothelial cells Even though their 
differentiating potential remains to be fully established, it is believed that 
their angiogenic ability is in itself a useful property for allogenic use. These 
cells can be expanded rapidly, providing numbers which are adequate for 
therapeutic neovascularization; again, being recovered from young and 
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healthy donors, they can be cryostored in appropriate cell banking facilities 
for later use (Pasquinelli et al., 2007 b).  
Finally, the possibility to use human aortas from multiorgan heart-
beating donors offers the possibility to study the existence of precursors in 
adult tissue, e.g mesangioblasts. Moreover, the Cardiovascular Tissue Bank 
offers the facility of  different human blood vessels (veins, a. femoral, a. 
iliac and so on) in order to verify if a heterogeneity of resident stem cells in 
the blood vessels anatomically distinct exists. This topic could be important 
also to understand the pathogenesis of several peripheral vascular diseases 
and could give some indications for new therapeutic approach.  
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